CURRICULUM VITAE

NAME: Pablo José Sánchez, M.D.

BUSINESS ADDRESS: Department of Pediatrics Center for Perinatal Research Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases The Ohio State University - Nationwide Children's Hospital The Research Institute at Nationwide Children's Hospital 700 Children's Drive, RB3, WB5245 Columbus, Ohio 43205-2664 614-355-6638; 614-355-5724 (phone) 614.355.5899 (fax) [email protected]

CITIZENSHIP: USA

EDUCATION: 1973 – 1977 Seton Hall University South Orange, New Jersey B.S., Biology (Cum Laude) 1977 – 1981 University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania Doctor of Medicine

POSTGRADUATE TRAINING:

1981 – 1984 Pediatric Internship and Residency Children’s Hospital of Pittsburgh Pittsburgh, Pennsylvania 1984 – 1986 Neonatology Fellowship Babies Hospital Columbia-Presbyterian Medical Center New York, New York 1986 – 1988 Pediatric Infectious Diseases Fellowship University of Texas Southwestern Medical Center at Dallas Dallas, Texas POSITIONS HELD: 1988 – 1995 Assistant Professor of Pediatrics 1995 – 2001 Associate Professor of Pediatrics 2001 – 2013 Professor of Pediatrics (with tenure) Division of Neonatal-Perinatal Medicine Division of Pediatric Infectious Diseases University of Texas Southwestern Medical Center at Dallas

1 Dallas, Texas 2013 - Present Professor of Pediatrics (with tenure) Division of Neonatal-Perinatal Medicine Division of Pediatric Infectious Diseases The Ohio State University - Nationwide Children’s Hospital, Columbus, OH

HOSPITAL AFFILIATIONS: 1998 – 2013 Parkland Health & Hospital System 5201 Harry Hines Blvd. Dallas, TX 75235

1998 – 2013 Children’s Medical Center of Dallas 1935 Medical District Drive Dallas, TX 75235

2013 – Present Nationwide Children’s Hospital 700 Children’s Drive Columbus, OH 43205

2014 – Present Wexner Medical Center at Ohio State University 410 W 10th Ave Columbus, OH 43210

COMMITTEES: 1988 – 2013 Member, Infection Control Committee Parkland Health and Hospital System

1995 – 2013 Committee of Infectious Diseases and Immunizations, Texas Pediatric Society, (Chair, 2004- 2009; Emeritus Chair, 2010-2011)

1997 – Present Member, Collaborative Antiviral Study Group, University of Alabama at Birmingham (NIAID)

1998 – 2000 UTSWMC representative, Texas Neonatal Clinical Research Study Group

2004 – 2013 Parkland Health & Hospital System Credentials Committee; Privileges Sub-Committee (Pediatric/Neonatology representative)

2004 – 2007 March of Dimes Parkland NICU Family Support Project Advisory Board

2 2006 – 2013 Institutional Review Board (#3), Alternate Member (UTSW)

2006 – 2013 Member, PMH Immunization Committee

2007 – 2013 Pharmacy & Therapeutics Committee, Children’s Medical Center Dallas (Neonatology, Pediatric Infectious Diseases representative)

2007 – 2010 Vaccines and Related Biological Products Advisory Committee, Food and Drug Administration (FDA)

2009 – 2015 Member, NICHD Pediatrics (CHHD-A) Subcommittee Grant Review Panel

2010 - 2012 FDA Pediatric Advisory Committee Meeting (Pediatric vaccines)

2011 – 2013 Member, Antimicrobial Stewardship Committee, Children’s Medical Center Dallas

2012 – 2015 Pediatric Academic Societies Meeting: Program Committee (PIDS; 2013-2015)

2014 – Present The Ohio State University College of Medicine Admissions Committee

CERTIFICATION: American Board of Pediatrics: 11/16/86 Board of Perinatal-Neonatal Medicine: 11/3/89; re-certification: 1996, 4/30/2002, 12/31/2010 - present. Board of Pediatric Infectious Diseases: 11/15/94, re-certification: 5/28/2000, 10/2008, through present

LICENSE: Pennsylvania New York Texas Ohio

SOCIETY MEMBERSHIPS: American Academy of Pediatrics (Sections on Perinatal Medicine and Infectious Diseases; Texas, Ohio Chapters)

Infectious Diseases Society of America (IDSA, Fellow)

3 Pediatric Infectious Diseases Society (Nominations and Awards Committee, elected post, 2005-2007; Council member, elected post, 2011-2015; Program committee, 2013-present)

Society for Pediatric Research (Membership Secretary, elected post, 1999-04)

Texas Pediatric Society (Committee on Infectious Diseases and Immunizations; Co-chair 2002-2003; Chair 2004-2009; through 2013)

Southern Society for Pediatric Research (through 2013)

Texas Infectious Diseases Society (through 2013)

Society for Healthcare Epidemiology of America (SHEA; member, Pediatric Leadership Council)

American Pediatric Society (1/2008-present)

Infectious Diseases Society of Ohio (1/2015-present)

European Society of Pediatric Infectious Diseases (ESPID; 2015-present)

Central Ohio Pediatric Society (COPS; 2015-present)

HONORS:

Session Chair, Neonatal Infectious Diseases, Pediatric Academic Societies’ Meeting (SPR), 5/8/96; 5/14/05, 6/2009

Invited Participant, “Infection Control: A Focus on MRSA,” Consensus Panel, SmithKline Beecham, Virginia, 11/17 – 19/1995

Who’s Who in Medicine: 1995 – Present (#135076, Life member of National Register of Who’s Who, published 2002 edition)

The Best Doctors in America: Central Region, 1996-1997

The Best Doctors in America: 1998 – Present

Invited Participant, Centers for Disease Control and Prevention, Congenital Syphilis: 1998 STD Treatment Guidelines, 2/10–13/97; 2001 STD Treatment Guidelines, 9/26–28/2000; 2005 STD Treatment Guidelines, 4/19-21/05; 2010 STD Treatment Guidelines, 4/28-30/09; 2015 STD Treatment Guidelines, 5/2013

Invited Panelist, “The RSV-Asthma Link: The Emerging Story”, American Thoracic Society, Dallas, TX, 11/23/98

4

Collaborator (Syphilis), 2000, 2006, 2009, 2012 Red Book: Report of the Committee on Infectious Diseases, American Academy of Pediatrics

Outstanding Scientific Contributions to Public Health, Nominee, 2001 STD Treatment Guidelines Team, CDC

The Best Pediatricians in Dallas (Pediatric Infectious Diseases), D Magazine, 2002-2013

America’s Top Pediatricians, 2002 – 2007

Invited Expert Panelist, “Human anti-staphylococcal hyperimmunoglobulin for prevention of staphylococcal infections in preterm infants,” 9/10/2002 (INHIBITEX, Inc.)

Invited Member, Editorial Advisory Board, Infectious Diseases in Children, 2003-present

2003 Golden Hands Award, given by PMH Infection Control Dept. for recognition of employee infection control awareness

Ray Kroc Visiting Professor Fellowship, Massachusetts General Hospital, Boston, MA, 1/28- 1/31/2003

Invited Medical Faculty, InfaCare Infant Wellness Initiative, National Minority Health Month Foundation, Inc. 2003

Invited Speaker, The 4th Annual Dr. John J. Fangman Neonatology Lectureship, Children’s Hospitals and Clinics, Minneapolis, MN, 10/18-19/2004

Invited Speaker, Symposium on “The Return of Syphilis,” 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 11/2/04

Invited Guest, WHO Department of Reproductive Health and Research Controlling Sexually Transmitted and Reproductive Tract Infections, “Technical Consultation on the Elimination of Congenital Syphilis,” Geneva, Switzerland, 12/1-2/04

Invited Member, Numax Advisory Committee (MI-CP110), MedImmune, Inc., 2005.

Invited External Consultant, Center for Disease Control and Prevention, U.S. Syphilis Elimination Effort (SEE), Atlanta, GA, 8/1-2/2005

Invited Speaker, 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 9/27/2006 (“The State of Antifungal Prophylaxis in Young Infants”)

5 Invited Speaker, Children’s Medical Research Institute Aliya Hefner Endowed Research Program, University of Oklahoma Health Sciences Center, Children’s Hospital of Oklahoma, Oklahoma City, OK, 8/30/2007 (“Congenital CMV: What’s New?”)

Invited Expert Consultant, “Expert Consultation on Community-Based Approaches for Neonatal Sepsis Management,” London, England (Save the Children/Saving Newborn Lives, US Agency for International Development, WHO, Boston Univ. Center for International Health And Development, Johns Hopkins Univ. School of Public Health, Univ. of London, Centre for International Health and Development), 9/26-28/2007

Invited Participant, University of Alabama at Birmingham Collaborative Antiviral Study Group Leadership Retreat, Bethesda, MD, 12/3-4, 2007

Invited Representative, Society for Healthcare Epidemiology of America (SHEA), CDC-GBS Guidelines Meeting, CDC, Atlanta, GA, 6/22/23/09

Society for Pediatric Research, nominating committee, 2009

Dallas Area Breastfeeding Alliance, Recognition Award for Outstanding Support of Breastfeeding, 8/2009

Invited Speaker, University of Minnesota, Minneapolis, MN, 4th Annual Jamie McNew Endowed Fellowship Lectureship, Grand Rounds, 2/10/10 (“Perinatal Infections: Overview and Update”)

Pfizer Visiting Professor, Albany Medical Center, Albany, NY 9/29-10/1/2010

Invitee, Future Directions Meeting (STD), Centers for Disease Control and Prevention, Atlanta, GA, 9/21/11

Invited Usher Lecture, “Congenital CMV Infection: What Now?” Pediatric Grand Rounds, McGill University, Montreal, Canada, 10/23/12.

Consultant, Global Experts Meeting (GEM), AbbVie, 2012-2014

Invited Participant (Society for Healthcare Epidemiology of America representative), Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC, 2010

Top Doctors (Pediatric Infectious Diseases), Columbus Monthly, 2014 – 2016

Nationwide Children’s Hospital Neonatology Fellows: 2015 Distinguished Faculty Award

Invited Participant, Syphilis Summit meeting, CDC, Atlanta, GA, 1/26-28/16

"Best of the Best", The American Registry, 2016

6 NIH, Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section (IRAP), San Francisco, CA, 6/9-10/16

MENTORSHIP:

Pre-Med Students: Nicholas Heyne UT Southwestern 2005 Jon Gonzalez UT Southwestern 2005 Cherise Ali UT Southwestern 2006 Shawn Varghese UT Southwestern 2011 - 2013 Phillip Wozniak UT Southwestern 2012 - present

Medical Students: Justin Smith UT Southwestern (MS4) 2006 Yin Chang UT Southwestern (MS2) Summer, 2006 Carlos de Oliveira UT Southwestern (MS2) Summer, 2006 Andrew Kleinberg UT Southwestern (MS2) Summer, 2008 Erik Bustamante UT Southwestern (MS2) Summer, 2008 Elaine Duryea UT Southwestern (MS1-2) Summer 2006, 2007 Ernest Fischer UT Southwestern (MS4) 2009 Katherine Claridge UT Southwestern (MS4) 2009 Jessica Williams The Ohio State College of Medicine 2016 - present

Residents: April Palmer, MD Children’s Medical Center Dallas 1995 Erik Benzick, MD Children’s Medical Center Dallas 1999 Mehul Patel, MD Children’s Medical Center Dallas 2010 Carlos de Oliveira, MD Children’s Medical Center Dallas 2010-2012 Natasha Hanners, MD Children’s Medical Center Dallas 2010-2013 Andrea Ronchi, MD Milan, Italy 2011-present Lisa Scheid, MD Children’s Medical Center 2012-present Alaina Pyle Children’s Medical Center 2013-present Joshua Cooper, MD Nationwide Children’s Hospital 2014-present Avante Milton Nationwide Children’s Hospital 2016-present

Fellows: Sithembiso Velaphi, MB UT Southwestern (NEO) 1998-2001 Ian Michelow, MB UT Southwestern (PID) 1998-2001 Wendy Chung, MD UT Southwestern (PID) 2002-2005 Asuncion Mejias,MD UT Southwestern (PID) 2003-2006 Monica Ardura, DO UT Southwestern (PID) 2004-2007 Roberto Santos, MD UT Southwestern (PID) 2005-2008 Amanda Evans, MD UT Southwestern (PID) 2009 Tara Dupont , MD UT Southwestern (NEO) 2008-2011 Eduardo Lopez-Medina, MD UT Southwestern (PID) 2009-2012

7 Katherine Stumpf , MD UT Southwestern (NEO) 2010-2013 Joseph B. Cantey, MD UT Southwestern (PID/NEO) 2010-present Charitharth (Vivek) Lal, MD UT Southwestern (NEO) 2012-2014 Natalie O. White, DO Nationwide Children’s Hospital – 2013-2016 OSU (NEO) Joshua Watson, MD Nationwide Children’s Hospital (PID) 2013-2015 Christopher Ouellette, MD Nationwide Children’s Hospital (PID) 2013-present Katherine Moyer, MD Nationwide Children’s Hospital (PID 2013-2016 Angela Firestine, MD Nationwide Children’s Hospital – 2014-present OSU (NEO) Claudia Vicetti Miguel Nationwide Children’s Hospital (PID) 2014-present

Other: Anne Ikonne, MPH UT School of Public Health Dallas 2009-2010

Visiting Scientist: Miguel Angel Osorio, MD Cali, Colombia 1993-1994 Mohamed WA Egypt 1998-2000 Amit Kumar Jaiswal India 2007-2008

Faculty: Elizabeth Stehel, MD UT Southwestern (NEO) 2005-present Monica Fonseca-Aten UT Southwestern (PID) 2005-2006 Asuncion Mejias, MD, PhD UTSW; Nationwide Children’s, Ohio 2006-present (PID) Lina Chalak, MD, MSCS UT Southwestern (NEO, Clinical 2008-present Scholar) Li Ern Chen, MD UT Southwestern (SURGERY, 2011-2013 Clinical Scholar) Mohannad Moallem, MD Nationwide Children’s Hospital; OSU 2014-present

LECTURES: Columbia-Presbyterian Medical Center Regional Perinatal Network, “Antibiotics in the Newborn”, New York, NY, January and April, 1986.

Sexually Transmitted Disease Clinician Advanced Training Course, Public Health Department, “STD’s in Newborn and Pregnancy”, 1987-1988; “HIV and Newborns”, Dallas, TX, 1991-1993. Humana Hospital – Medical City Dallas, “Prevention of Neonatal Group B Streptococcal Disease: Current Concepts”, Dallas, TX, August, 1991.

Pediatric Grand Rounds, UT Southwestern Medical Center/Children’s Medical Center of Dallas, “Congenital Syphilis”, Dallas, TX, August, 26, 1991.

8 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, “Congenital Syphilis: Epidemiology, Diagnosis and Pathogenesis”, Symposium on Congenital and Perinatal Infections, Chicago, IL, October 2, 1991.

American Academy of Pediatrics, Joint Session on Perinatal and Infectious Diseases, “The Reemergence of Syphilis as a Neonatal Pathogen: Epidemiology, Diagnostic Techniques, and Therapy”, New Orleans, LA, October 26, 1991.

The Changing Role of Mycoplasmas in Respiratory Disease and AIDS, “Ureaplasma urealyticum Colonization of Premature vs. Term Infants”, Scottsdale, AZ, December 2, 1991.

Centers for Disease Control, Sexually Transmitted Diseases Branch, “Congenital Syphilis: New Aspects of Diagnosis”, Atlanta, GA, December 17, 1991.

Symposium on the High-Risk Neonate, in honor of “Luis Alfonso Cabal”, Cirena Foundation, “Congenital Syphilis”, “Nosocomial Infections in the NICU”, “Neonatal Ureaplasma urealyticum Infections”, Cali, Columbia, June, 1993.

Presbyterian Hospital, “Perinatal Update 1993: Group B Strep”, Dallas, TX, November 18, 1993.

The 26th Annual Kenneth C. Haltalin Pediatrics Seminar, UT Southwestern Medical Center, “The Febrile Infant”, Dallas, TX, November 5, 1993.

XIII Interamerican Congress of Pediatric Infectious Diseases, “Congenital Syphilis”, Guanajuato, Mexico, December 3, 1994.

The Dallas Area Conference on Perinatal and Pediatric Health (March of Dimes), “What’s Bugging Baby? (Viral Infections)”, Dallas, TX, March 30, 1995.

Charlton Methodist Hospital Family Practice Center, “Congenital Infections”, Dallas, TX, June 13, 1995.

NeoPREP: Neonatal/Perinatal Medicine Review Course, American Academy of Pediatrics, “AIDS and Sexually Transmitted Diseases”, September 16, 1995.

Sexually Transmitted Diseases Seminar, Dallas County Health Dept., “Congenital Syphilis: The Dallas Experience”, Dallas, TX, September 25, 1995.

UT Southwestern Medical Center, The At-Risk Newborn: Current Update for Primary Care Physicians, “Perinatal Group B Streptococcal Infection: Management Strategies”, Dallas, TX, October 7, 1995.

Columbia-Presbyterian Medical Center, Babies Hospital, Neonatology Research Conference, “New Aspects in Diagnosis of Congenital Syphilis”, November 22, 1995.

9 Infectious Diseases: Mother, Infant & Health Care Worker, Parkland Memorial Hospital, “Herpes in Neonates”, Dallas, TX, April 16, 1996.

Dermatology Grand Rounds, UT Southwestern Medical Center, “Herpes Virus Infection: Neonatal Herpes and Varicella”, Dallas, TX, May 23, 1996.

Congress of Neonatology (II Jornada Sul-Rio-Grandense de Neonatologia), “Congenital Cytomegalovirus Infection”, “Congenital Toxoplasmosis”, Congenital Syphilis”, and “Neonatal Herpes Infection”, Passo Fundo, Brazil, May 30 – June 1, 1996.

II International Symposium on Perinatal Infectious Diseases (FUNCEI), “Syphilis in the Pregnant Woman and Newborn: An Update”, and “Role of Mycoplasma sp. and Chlamydia trachomatis in Perinatal Infections”, Buenos Aires, Argentina, July, 1996.

1996 NeoPREP Course, American Academy of Pediatrics, “AIDS and Sexually Transmitted Diseases”, Small Group Infectious Diseases Case Discussions, St. Petersburg, FL, October, 1996.

2nd Annual UT Southwestern Medical Center, The At-Risk Newborn: Current Update for Primary Care Physicians, “Newer Strategies for the Prevention/Treatment of Neonatal Infections”, Dallas, TX, October 12, 1996.

1st Annual Neonatal Advance Practice Pharmacology Conference, Parkland Memorial Hospital, UT Southwestern Medical Center, “Neonatal Infections: A Focus on Group B Streptococcal and Ureaplasma Urealyticum”, Dallas, TX, October 24, 1996.

Neonatology Symposium, University of Texas Medical Center, “Group B Streptococcal Prophylaxis in the Neonate”, Tyler, TX, October 31, 1996.

Neonatology Research Conference, Baylor Hospital, “Use and Abuse of the Group B Streptococcal Urine Latex Agglutination Test in Neonates”, Dallas, TX, November 7, 1996.

1997 CDC STD Treatment Guidelines Meeting, CDC, “Congenital Syphilis”, Atlanta, GA, February 10, 1997.

Pediatric Grand Rounds, UT Southwestern Medical Center/Children’s Medical Center of Dallas, “Ureaplasma Urealyticum as a Neonatal Pathogen: Fact or Fiction?” Dallas, TX, February 26, 1997.

University of Texas Health Science Center at Tyler, Trinity Mother Frances Health System, “Congenital Syphilis”, Tyler, TX, June 3, 1997.

3rd Annual Neonatology Conference of the Neonatology Society of Costa Rica, “Congenital Syphilis”, “Neonatal Sepsis” and “Ureaplasma urealyticum”, San Jose, Costa Rica, August 6–8, 1997.

10 Pan American Health Organization/WHO, Workshop for STD Management, “Congenital Syphilis: State of the Art”, Santa Cruz, Bolivia, August 18-22, 1997.

NeoPREP: An Intensive Review Course of Neonatal/Perinatal Medicine, American Academy of Pediatrics, “AIDS and STDs”, Phoenix, AZ, September 15-21, 1997.

UT Southwestern Medical Center, The At-Risk Newborn: Current Update for Primary Care Physicians, “Management of the Infant at Risk for Herpes Infection”, Dallas, TX, October 4, 1997.

Latin American Congress on Sexually Transmitted Diseases/Pan-American Conference on AIDS, “What’s New in Congenital Syphilis”, Lima, Peru, December 3-6, 1997.

2nd Annual Neonatal Advanced Practice Pharmacology Conference, Parkland Health & Hospital System, “Perinatal Infections: Therapy Update”, Dallas, TX, January 28, 1998.

MEDI-493 Investigator’s Meeting, MI-CP011: A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of MEDI-493, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, Administered Intramuscularly in Children with a History of Prematurity or BPD, La Jolla, CA, February 27-28, 1998.

Pediatric Grand Rounds, St. Joseph’s Hospital, “Congenital Syphilis”, Patterson, NJ, April 14, 1998.

The 18th Annual National Pediatric Infectious Disease Seminar, “Ureaplasma and Newborns” and “Antibiotics in Neonates”, Washington, DC, April 15-18, 1998.

National Association of Neonatal Nurses, “Use and Misuse of the Urine GBS Latex Agglutination Test”, Dallas, TX, April 24, 1998.

Pediatric Academic Societies’ 1998 Annual Meeting/Society for Pediatric Research, Mini Course, “What’s New in Congenital Syphilis – An Update on Management and Treatment”, New Orleans, LA, May 1-5, 1998.

Perinatal Update, McAllen Medical Center, “Update on Select Perinatal Infections – A Pediatric Perspective”, McAllen, TX, August 29, 1998.

Pediatric Grand Rounds, UT Southwestern Medical Center/Children’s Medical Center of Dallas, “Taking Aim at RSV: Prevention at Last?”, Dallas, TX, September 16, 1998.

Pediatric Grand Rounds, Memorial Medical Hospital, “Taking Aim at RSV: Prevention at Last?”, Savannah, GA, October 2, 1998.

Ross Laboratories, “RSV Prophylaxis”, Irving, TX, October 14, 1998.

11 Prevention of Respiratory Syncytial Virus (RSV) Disease in High-Risk Patients, A Satellite Symposium (AAP), “Risk Factors for Severe RSV Disease”, San Francisco, CA, October 16, 1998.

American Academy of Pediatrics, Section on Infectious Diseases, “Congenital Syphilis: What Does the Pediatrician Need to Know?”, San Francisco, CA, October 19, 1998.

Grand Rounds, Cook Children’s Medical Center, “Congenital Syphilis”, Fort Worth, TX, October 27, 1998.

St. Paul Family Practice Center, “Congenital Infections”, Dallas, TX, October 28, 1998.

Infectious Disease and Infection Control Symposium, Methodist Hospital, “Taking Aim at RSV: Prevention at Last?”, Lubbock, TX, November 7, 1998.

Prevention of Respiratory Syncytial Virus (RSV) Disease in High-Risk Patients, A Satellite Symposium (IDSA), “Risk Factors for Severe RSV Disease”, Denver, CO, November 12, 1998.

3rd Annual Neonatal Advanced Pharmacology Conference, Parkland Health & Hospital System, “Antibiotics in Newborns”, Dallas, TX, January 29, 1999.

Pediatric Grand Rounds, Miami Children’s Hospital, “Congenital Syphilis”, Miami, FL, February 19, 1999.

Approaches to Prophylaxis and Treatment of Pediatric Infectious Diseases, “Respiratory Syncytial Virus: Clinical History and Epidemiology”, Washington, DC, March 5, 1999.

1999 Issues in Neonatology (Ross Labs Conference), “Congenital Infections: It’s Just Not TORCH”, Long Island, NY, March 11, 1999.

The 19th Annual National Pediatric Infectious Disease Seminar, “Decision Making in Neonatal Infections”, “RSV Prophylaxis”, San Diego, CA, April 7-10, 1999.

MedImmune Training Meeting, “RSV Infection and Risk Factors for Severe Disease”, Gaithersburg, MD, May 11, 1999.

American Academy of Pediatrics, District VIII, Section on Perinatal Pediatrics, 2nd Annual Conference on Neonatal/Perinatal Medicine, “Taking Aim at RSV: Prevention at Last?”, Welches, OR, May 30, 1999.

Child Abuse and Neglect Grand Rounds, Children’s Medical Center of Dallas, “Is It An STD? Is It Abuse?”, Dallas, TX, August 6, 1999.

NeoPREP: An Intensive Review Course on Neonatal/Perinatal Medicine, American Academy of Pediatrics, “HIV/STD”, “Cases in HIV/STD”, San Antonio, TX, August 26-27, 1999.

12 Prevention of Respiratory Syncytial Virus: From Hospital to Outpatient Setting, “Preventing RSV in the High-Risk Patient”, Grapevine, TX, September 11, 1999.

Pediatric Grand Rounds, University of Tennessee, LeBonheur Children’s Medical Center, “Congenital Syphilis”, “Case Presentation: Congenital Infections”, Memphis, TN, September 15, 1999.

Pediatric Grand Rounds, Montreal Children’s Hospital, “Recent Advances in Prophylaxis and Treatment of RSV Infections”, Montreal, Canada, September 22, 1999.

Pediatric Grand Rounds, Hospital Sainte-Justine, “Recent Advances in Prophylaxis and Treatment of RSV Infections”, Montreal, Canada, September 22, 1999.

The McGill Pediatric Network Infectious Diseases Research Rounds, “Recent Advances in Prophylaxis and Treatment of RSV Infections”, Montreal, Canada, September 22, 1999.

American Academy of Pediatrics UPDATE audio cassette tape series, “Perinatal Infections”, (Speaker and Moderator), Washington, DC, October 11, 1999.

American Academy of Pediatrics, 1999 Annual Meeting, “Perinatal Infections: Case Presentations on Diagnosis and Treatment (3-Hour Interactive Case-Based Sessions)”, Washington, DC, October 12, 1999. National Satellite Conference (Panelist), UT Southwestern Medical Center, “STD Diagnostic and Therapeutic Dilemmas: Gonococcal and Chlamydial Infections”, Dallas, TX, October 14, 1999.

Focus on Respiratory Syncytial Virus, “Immunoprophylaxis of RSV Disease”, Four Seasons Hotel, Las Colinas, TX, October 15 - 16, 1999 (course co-organizer, sponsored by UT Southwestern Medical Center).

World Society of Pediatric Infectious Diseases, “Congenital Syphilis”, Manila, Philippines, November 3, 1999.

Pediatric Grand Rounds, University of Texas Health Science Center at Houston, “Congenital Syphilis”, and noon conference, “Nosocomial Infections in the NICU”, Houston, TX, December 14, 1999.

MedImmune, Inc. (sponsor) and UT Southwestern Medical Center, “RSV Prevention and Management: A Preceptorship for Case Managers”, Dallas, TX, February 24 and 27, 2000. The 1st International Symposium in Pediatrics Update, American University of Beirut, “STD and Neonatal Morbidity” and “RSV Prophylaxis”, Beirut, Lebanon, March 30–April 2, 2000.

The 20th Annual National Pediatric Infectious Disease Seminar, “IV Catheters for Antibiotic Administration”, New Orleans, LA, April 26-29, 2000.

Pediatric and Adolescent Provider Forum Series, Parkland Health & Hospital System (COPC), “RSV Prevention, Dallas, TX, September 6, 2000.

13

2000 CDC STD Treatment Guidelines Meeting, CDC, “Congenital Syphilis”, Atlanta, GA, September 26-28, 2000.

3rd Annual Update on RSV, Sponsored by UT Southwestern Medical Center and ICN Pharmaceuticals, “Immunoprophylaxis for RSV Disease”, Dallas, TX, October 14, 2000.

24th Annual International Conference, The University of Miami School of Medicine, Neonatology 2000, “Congenital Infection Work-up”, “Nosocomial Infections in the NICU”, and “Congenital Syphilis”, Key Biscayne, FL, November 9-11, 2000.

Pediatric Grand Rounds, Children’s Hospital of Austin, “Congenital Syphilis”, Austin, TX, February 22, 2001.

The 33rd Annual Kenneth C. Haltalin Pediatrics Seminar, UT Southwestern Medical Center, “Congenital Infection”, Dallas, TX, March 23-24, 2001.

Neonatal Nurse Practitioners (NNP) Update 2001 Conference, Parkland Health and Hospital System, “Treatment of Anaerobic Neonatal Infections”, Dallas, TX, May 22, 2001.

Synagis (Palivizumab) Practice Management Program, “Overview of RSV Disease and Current Preventive Strategies”, Four Seasons Conference Center, Las Colinas, TX, June 16, 2001. NeoPREP: An Intensive Review Course of Neonatal/Perinatal Medicine, American Academy of Pediatrics, “HIV/STD”, “Cases in HIV/STD”, Boston/Cambridge, MA, August 24, 2001.

Pediatric Grand Rounds, Scott & White Hospital, “Congenital Syphilis”, Pediatric Noon Conference, “Congenital Infections”, Temple, TX, September 5, 2001.

XVII Brazilian Congress of Perinatology, “GBS Infection”, “Congenital Syphilis: Update on Management”, and “Fungal Infection”, Florianopolis, Brazil, November 10-14, 2001.

Sexually Transmitted Diseases Seminar, Dallas County Health Dept. (with Jeanne Sheffield, M.D.), “Syphilis in the Pregnant Woman and Infant”, Dallas, TX, December 10, 2001.

Nutrition for a Lifetime: A Breastfeeding Seminar, Parkland Health and Hospital System, Dept. of Nursing, “Infection and Breastfeeding”, Dallas, TX, February 6, 2002 and June 19, 2002.

11th Annual Neonatology Conference at Nemacolin Woodlands Resort, “Prevention and Treatment of Nosocomial Infections in the NICU”, Farmington, PA, February 13-15, 2002.

Annual STD Conference, OCASET, “Congenital Syphilis”, San Juan, Puerto Rico, February 23, 2002.

Pediatric Grand Rounds, UT Southwestern Medical Center/Children’s Medical Center of Dallas, “Congenital Cytomegalovirus Infection”, Dallas, TX, April 24, 2002.

14 Pediatric Academic Societies’ 2002 Annual Meeting, Shifting Paradigms of Neonatal Sepsis Mini-Course, “Antimicrobial Utilization in the NICU: Strategies to Reduce Resistance”, Baltimore, MD, May 4, 2002 (program moderator).

Pediatric Grand Rounds, St. Joseph’s Hospital, “Congenital CMV Infection: Time to Treat?”, Patterson, NJ, May 21, 2002.

Pediatric Grand Rounds, Cook Children’s Medical Center, “Congenital Cytomegalovirus Infection”, Fort Worth, TX, August 6, 2002.

Pediatric Grand Rounds, University of Texas Medical Branch, “Antimicrobial Utilization in the NICU: Strategies to Reduce Resistance,” Galveston, TX, September 6, 2002.

III International Congress on Neonatology, Hospital Italiano de La Plata, “Congenital Syphilis”, “Nosocomial Infections in the NICU”, and “Fungal Infections in the NICU”, La Plata, Argentina, September 18-20, 2002.

Symposium on Advances in the Prevention of RSV Infection, “New Perspectives on Prophylaxis of RSV Infection,” “RSV Prophylaxis: the Congenital Heart Disease Trial,” Madrid, Spain, 11/3-4/2002.

Fourth Annual Pediatrix-Obstetrix Center for Research and Education Consensus Conference. Nosocomial Sepsis in the NICU: A Medical Complication or Unavoidable Problem? “How Do We Decide Who Has Sepsis?” “Treatment Decisions for Bacterial Sepsis,” Houston, TX, 11/7/2002. Pediatric Grand Rounds, Medical City Dallas Hospital, “Group B Strep Prevention: Neonatal Management,” Dallas, TX, 11/12/2002.

UNIDOS 2002: Developing Leadership in Healthcare, Congenital Syphilis Today: A Preventable Health Problem,” Las Cruces, New Mexico, 11/22/2002.

Ray Kroc Visiting Professor Fellowship, “Vancomycin Utilization and Antibiotic Resistance in the NICU: Can We Make a Difference?” (Grand Rounds), “Central Venous Catheter Infections in the NICU,” “Congenital CMV Infection,” “Congenital Syphilis,” Massachusetts General Hospital, Boston, MA, 1/28-1/31/2003.

Pediatrix, “Early-onset GBS Disease and Maternal Chorioamnionitis: Neonatal Management,” Dallas, TX, 2/26/2003.

The Society for Healthcare Epidemiology of America (SHEA) 13th Annual Scientific Meeting, Symposium: Meeting the Challenges of Pediatric Infection Control, “Vancomycin Reduction in the NICU: It Can Be Done!” Arlington, VA, 4/7/2003.

The High Risk Neonate & Maternal Care, McAllen Medical Center, “Diagnosis and Management of Active Syphilis,” “Current CDC Guidelines for GBS,” McAllen, TX, 4/12/2003.

15

Neonatal Sepsis Club, Pediatric Academic Societies’ Meeting, “Hot Topics in Pathogenesis and Treatment of Gram-negative Sepsis and Shock: Treatment,” Seattle, WA, 5/4/03.

Neonatology Conference, “Vancomycin Reduction in the NICU: It Can Be Done!” Baylor Hospital, Dallas, TX, 5/15/03.

Infection and Immunity in Children 2003, “Bacterial and Fungal Infection in the Neonate – Current Diagnosis and Therapy,” University of Oxford (St. Catherine’s College), Oxford, UK, 6/29 - 7/1/03.

II International Course on Neonatology, “Congenital Syphilis: Diagnosis and Therapy,” “Congenital Cytomegalovirus: Diagnosis and Therapy,” “Group B Strep Prophylaxis,” “RSV Prophylaxis: Emphasis on the Results of the Congenital Heart Disease Trial,” Curitiba, Brazil, 7/31 – 8/2/03.

NeoPREP: An Intensive Review Course of Neonatal/Perinatal Medicine, American Academy of Pediatrics, “HIV/STD”, “Nosocomial Infections,” “Cases in HIV/STD”, Vancouver, Canada September 12-13, 2003.

Neonatal Update II: Pearls from the Gulf Coast, “Nosocomial Infections: What’s Going Around Now?”, “Congenital CMV Infection: To Treat or Not to Treat,” Galveston, TX, October 24-26, 2003.

8th World STI/AIDS Congress (XIV Pan-American STI/AIDS Congress; 40th IUSTI World General Assembly), “The Pathophysiology of Congenital Syphilis,” Punta Del Este, Uruguay, 12/2-5/2003.

University of Rochester Neonatology Research Seminar, “Congenital Syphilis,” Rochester, NY, 3/15/2004.

V Curso Internacional: Avances en Pediatria Neonatal, “General Vision and Diagnosis of Congenital Infections,” “Complication of Congenital and Perinatal Central Nervous System Infections,” “Nosocomial Infections in the NICU,” “RSV Prophylaxis in High-Risk Infants,” Concepcion, Chile, 4/14-17/2004.

Reunión Regional de Expertos de Sífilis Congénita, Pan American Health Organization, “Congenital Syphilis,” Santo Domingo, Dominican Republic, 5/10-11/2004.

XXXVIIIth Middle East Medical Assembly (MEMA), “PROM and Tocolysis: Neonatal Effects and Management,” “Group B Strep Neonatal Management Protocols,” “Nosocomial Infections: Strategies and Implications,” Beirut, Lebanon, 5/13-16/2004.

Elimination of Congenital Syphilis in the Americas - A Task Within Reach, Pan American Health Organization, “Congenital Syphilis,” Washington, DC, 6/1/2004.

16

The 4th Annual Dr. John J. Fangman Neonatology Lectureship, “A Practical Approach to Primary and Secondary Infections in the NICU,” “Bugs and Drugs in the NICU: Can We Make a Difference? (Grand Rounds),” Children’s Hospitals and Clinics, Minneapolis-St. Paul, MN, 10/18-19/2004

“Congenital Syphilis,” 2004 UNIDOS Conference, Las Cruces, NM, 10/27/2004

“Congenital Syphilis: A Continuing Problem,” 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 11/2/04

“Evidence-Based Approaches to the Prevention of Microbial Resistance,” “Late-Onset Sepsis— Organisms and Antibiotic Selection for Systemic and GI Disease,” Neonatal Pharmacology Conference 2004, Charleston, SC, 11/16/04

“Vancomycin Reduction in the NICU: It Can Be Done!” Neonatology Research Conference, Cook Children’s Hospital, Fort Worth, TX, 6/14/05

John Peter Smith Hospital Resident Conference, “Congenital Syphilis,” Fort Worth, TX, 8/25/05

World Society for Pediatric Infectious Diseases (WSPID), “Nursery Infections,” Warsaw, Poland, 9/1-4/2005

NeoPREP: An Intensive Review Course of Neonatal-Perinatal Medicine, American Academy of Pediatrics, “Perinatal Transmission of Viral Pathogens and STDs”, “Early-onset and Nosocomial Infections,” “Cases of Infection,” San Diego, CA, September 18-24, 2005

New Concepts in Neonatal Intensive Care: A Collaborative Conference, “Management of Nosocomial Infections in the Premature Infant: Can We Avoid Drug Resistance?” New York City, NY, 9/23/2005

“Sífilis Congénita: un Antiguo Tema con un Enfrentamiento Moderno,” “Enfrentamiento Actual de la Infección por CMV en el Neonate,” XII Congreso Chileno de Infectologia, Sociedad Chilena de Infectologia, Puerto Varas, Chile, 10/26-29/2005

“Transmission of Genital Infections to Newborns,” The Eastern Pennsylvania Branch of the American Society for Microbiology, 36th National Symposium, University of Pennsylvania, Philadelphia, PA, 11/8-9/2005

“Congenital Syphilis: 2006,” (Grand Rounds) and “Congenital CMV: What’s New and Coming?” (Resident Noon Conference), SUNY Stony Brook, NY, 2/8/2006

“Diagnosis and Treatment of Congenital and Perinatal Infections” (Grand Rounds) and “Neonatal Infectious Diseases Issues” (Neonatology Fellows’ Conference), North Shore University Hospital, NY, 4/12/2006

17 “Congenital CMV Infection: To Treat or Not to Treat?”, Pediatric Nursing Clinical and Professional Update: Care for Kids, National Association of Pediatric Nurse Practitioners, Dallas, TX, 5/5/2006

“Hot Topics in Pathogenesis and Treatment of Gram-negative Sepsis and Shock,” 32nd Annual Meeting of the Swiss, Austrian & German Society of Neonatology and Pediatric Intensive Care Medicine, Vienna, Austria, 5/18-20/2006

“Congenital Syphilis and CMV,” “Nosocomial Infections in Neonatology,” “Transmission of Genital Pathogens to the Newborn,” XXXVI National Panamanian Congress of Pediatrics, Panama, 7/6-8/2006

“Congenital Syphilis in 2006: The Scourge Persists!” Pediatric Grand Rounds, UT Southwestern Medical Center/Children’s Medical Center of Dallas, Dallas, TX, 8/23/2006

“The State of Antifungal Prophylaxis in Young Infants,” 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 9/27/2006

“Congenital Syphilis in 2006: The Scourge Persists!” (Farrokh Shahrivar Lecture), “Systemic Candidiasis and Antifungal Prophylaxis in Preterm Infants,” St. Luke-Roosevelt Hospital Center, NYC, 10/23/06

“Newborn Infectious Disease Issues,” “Newborn Infectious Disease Issues – Part 2,” The Not- So-Scary Newborn Conference, Baptist Health System, San Antonio, TX, 10/27/2006

“Congenital Syphilis: It’s Still a Problem in 2007!”, “Nursery-acquired Infections: We MUST Do Better!”, “Systemic Candidiasis and Antifungal Prophylaxis,” 21st Annual Conference of the Southeastern Association of Neonatologists, Marco Island, Florida, 5/17-20, 2007

PREP:ID: A Comprehensive Review and Update of Pediatric Infectious Diseases, American Academy of Pediatrics, “Congenital Infections,” “Neonatal Infections: Case Vignettes,” Chicago, IL, 7/24/2007

NeoPREP: An Intensive Review Course of Neonatal-Perinatal Medicine, American Academy of Pediatrics, “Early-onset and Nosocomial Infections,” “Cases of Infection,” Atlanta, GA, August 21, 2007

“Congenital CMV: What’s New?” Children’s Medical Research Institute Aliya Hefner Endowed Research Program, University of Oklahoma Health Sciences Center, Children’s Hospital of Oklahoma, Oklahoma City, OK, 8/30/2007

“Infections in the NICU: Improvement Needed!” Women’s Hospital, Houston, TX, 9/24/07

“Neonatal Sepsis,” “CMV Infection” The High-Risk Neonate and Maternal Care Conference, McAllen Medical Center, McAllen, TX, 11/17/2007

18 “Prevention of Resistance by Limiting Antibiotic Exposure: Innovative Approaches in the Neonate,” 2008 Annual Conference on Antimicrobial Resistance, Bethesda, MD, 6/6/24/2008

“Neonatal Infections,” Advanced Neonatal Nursing Course, University of Texas at Arlington, School of Nursing, Arlington, TX, 9/5/2008

“Congenital CMV Infection: Time to Act (Grand Rounds),” “Neonatal Sepsis: The Use and Abuse of Empirical Antibiotic Therapy,” “Ureaplasma and Mycoplasma Colonization/Infection: What’s the Evidence Towards Investigation and Treatment?” McMaster University, Hamilton, Canada, 9/11-12/2008.

“Nursery-Associated Infections: We Can Do Better!” Thomas Pauly Excellence in Neonatology Lectureship, Pediatric Grand Rounds, and “Fungal Prophylaxis in the NICU: What is the Evidence?” Research dinner, University of Kentucky, Lexington, KY, 10/1-2/2008

“Congenital Infections: What the Pediatrician Should Know!” 2nd Annual Neonatology Conference at Scott and White, “Current Concepts and Footsteps for the Future,” Temple, TX, 11/12/2008.

“Manejo del recién nacido con diagnóstico presuntivo de sífilis,” “Infección por citomegalovirus: diagnóstico y tratamiento,” Congress on Pediatric Infectious Diseases and Vaccines, Buenos Aires, 4/16-17/2009

“Congenital Syphilis: Current Guidelines for Treatment in the Developed vs. Developing World, Congenital Syphilis-A public Health Issue of Concern: Focus on Latin America, Center for Global Health, Albany, NY, May 1, 2009

“Congenital CMV Infection and Hearing Loss: What Can We do?” 2nd Annual Current Topics in Congenital Hearing Impairment, and “Impact of Cytomegalovirus Infection on Neonatal Health,” NeoForum 2009, MidAtlantic Neonatology Associates, Morristown, NJ, June 11-12, 2009

“Congenital Syphilis,” “Fungal Infections and Prophylaxis,” “Neonatal Infections and Ureaplasma,” XIII Seminario Internacional: Avances en Pediatria Neonatal, Universidad Católica de Chile, Santiago, Chile, 10/7-9/2009

“Sífilis congénita, siempre vigente,” “Infecciones por hongos y profilaxis,” “Infección neonatal por Ureaplasma,” XIII Seminario Internacional “Avances en Pediatría Neonatal,” Pontificia Universidad Católica de Chile, Santiago, Chile, October 7-9, 2009 “CMV Infection in Neonates: Is There A Treatment?” International Conference on Clinical Neonatology, Turin, Italy, 11/12-14/2009

“Perinatal Infections: Overview and Update,” 4th Annual Jamie McNew Endowed Fellowship Lectureship, Grand Rounds, University of Minnesota, Minneapolis, MN 2/10/10

“Strategies to Limit Infections in the Neonate and Reduce Infection-Related Mortality,” 14th International Congress on Infectious Diseases, Miami, Florida, 3/11/2010

19

“Neonatal Infections: Improvement Needed!” for the Oregon Neonatal Seminar Series and “Congenital CMV Infection: Time to Treat,” Grand Rounds, Oregon Health & Science University (OHSU), Portland, Oregon, June 8-9, 2010

“Congenital Cytomegalovirus Infection” (Grand Rounds), “Congenital Syphilis,” “Neonatal Herpes Simplex Virus (HSV) Infection: Another TORCH? (Capital District Pediatrics Conference), Pfizer Visiting Professor, Albany Medical Center, Albany, NY 9/29-10/1/2010

“Sospecha Clinica y Diagnóstico Diferencial de TORCHS,” “Tópicos en el Tratamiento de Infecciones Congénitas,” XXII Curso Internacional de Pediatría, Viña del Mar, Chile September 9-11, 2010

“Sífilis Congénita, un Problema Persistente en América Latina,” II Congreso Internacional de Infectología Pediátrica y Vacunas, Buenos Aires, Argentina, 10-14-15/2010

“Congenital CMV and Herpes Infections: An Update,” “Strategies in Preventing Neonatal Infections,” Miami Neonatology 2010, 34th Annual International Conference, Miami Beach, FL, 11/4-6/2010

“Congenital CMV: State of the Art,” “ Congenital Syphilis: A Big Challenge,” XX Brazilian Congress of Perinatology, Rio de Janeiro, Brazil, 11/23-24/2010

“Hospital Acquired Infections in the 21st Century,” National Collaborative Perinatal Neonatal Network, Regional Bi-Annual Meeting, Beirut, Lebanon, 3/31-4/2/11

“Changing Epidemiology in the NICU,” Issues in Perinatal and Neonatal Care: 34th Annual Seminar, Women & Infants Hospital, Providence, RI, 4/21/11

“Congenital & Perinatal Infections,” UTSW School of Public Health, 8/30/11

“Infecciones Congenitas, Infecciones Neonatales,” I Taller Internacional en Genética Médica Círculo de Estudios de Genética Francis Collins – CEGFRAC, Chiclayo, Peru, 8/8-9/2011

“Sífilis Congénita,” “Infecciones Nosocomiales en Neonatología,” “Infección por CMV,” Segundo Congreso Nacional de Neonatologia, Medellin, Colombia, 8/25-26/2011

“Congenital Syphilis,” 27th Annual Update in STD/HIV/AIDS, Birmingham, AL, 11/8/2011

“Respiratory Viruses in the NICU: An Under-Recognized Burden,” “Workshop: Management and Control of Respiratory Viral Infections in the NICU,” Latin America Global Experts Meeting, Buenos Aires, Argentina, March 20-21, 2012

“Advances in the Prevention and Treatment of Herpes Simplex Virus Infection in the Newborn (Symposium),” “Congenital Cytomegalovirus Infection: Is It Time for Universal Newborn

20 Screening? (Workshop),” 2012 Pediatric Academic Societies Annual Meeting, Boston, MA, April 28, 2012

“Infección Neonatal Precoz: Cambios epidemiológicos,” “Estrategias para Disminuir las Infecciones Nosocomiales,” “Uso y Abuso de la Terapia antibiótica en UCI-Neonatal,” “Infecciones Virales en el RN en UCI,” Avances en Pediatría Neonatal, Concepción, Chile, May 9-12, 2012

“Respiratory Viruses in the NICU: An Under-recognized Burden?” State of the Art Symposium: Respiratory Illness Caused by RSV, Mexico City, Mexico, July 28, 2012

“Congenital & Perinatal Infections,” UTSW School of Public Health, 9/12/12

“Viral Infections and Viral Sepsis in the NICU,” “Ventilator-Associated Pneumonia in the NICU” (workshop), 10th Global Experts Meeting on Respiratory Viruses, Dusseldorf, Germany, September 19-20, 2012

“Infecciones Neonatales: Algunos Aspectos que Debieran Interesarle,” “Cándida: Infecciones y Profílaxis,” “Actualización en Infección Congénita por CMV y Sífilis,” “Infecciones Respiratorias Virales en UCIN,” V Congreso Chileno de Neonatología, Santiago, Chile, 10/3- 5/12

“Congenital CMV Infection: What Now?” (Pediatric Grand Rounds, Usher Lectureship), “Neonatal Herpes Infection: An Update,” “Use and Misuse of Antibiotics in the NICU: The Danger Ahead!,” McGill University; “Congenital CMV Infection: What Now?” “Congenital CMV Infection and Neonatal Herpes Infection” (Saint Justine Children’s Hospital); Montreal, Canada, 10/23-26/12.

“Viral Infections in the NICU: An Under-recognized Phenomenon?”, “Congenital CMV: Diagnosis and Treatment” (workshop), Latin America Global Experts Meeting on Respiratory Viruses, Mexico City, Mexico, March 12-13, 2013

“Congenital Syphilis: Knowledge Gained from Translational Research,” Nationwide Children’s Hospital, Columbus, OH, 2/15/13

“Congenital Syphilis: Knowledge Gained from Translational Research,” Emory University – Children’s Healthcare of Atlanta, GA, 3/18/2013

“Respiratory Viral infections in the NICU: An Under-Recognized Burden?’ in “Topic Symposium entitled “Respiratory Viral Infections: From the Lab to the Patient,” Pediatric Academic Societies meeting, Washington DC, 5/5/2013

“Congenital Syphilis,” Infection and Immunity in Children, St. Catherine’s College, Oxford, UK, 6/26-28/2013 “Hot Topics in Congenital and Perinatal Infections,” “Resident Case Conference in Neonatal Infections,” Levine Children’s Hospital, Carolinas Healthcare System, Charlotte, NC, 9/9/2013

21

“Fungal Prophylaxis (Workshop),” Global Experts Meeting, Vienna, Austria, 9/18-19/2013

“Antimicrobial Stewardship in the Neonatal ICU: Meet the Professor, IDWeek 2013, IDWeek, 10/2/13, San Francisco, CA

“Congenital Infections: An Update,” “Respiratory Viruses in the NICU,” 22nd Annual Amazing Newborns Conference, University of New Mexico, Albuquerque, New Mexico, 11/7-8/13

“Congenital CMV Infection: Progress and Remaining Challenges!” The Hospital for Sick Children, Toronto, Canada, 12/4/2013

“Viral Infections in the NICU: An Under-recognized Phenomenon,” “Evaluating the newborn for Congenital Infection: Beyond the TORCH!” University of Miami Miller School of Medicine, Miami, FL, 12/12-13/13

“Congenital and Perinatal Infections I & II,” Ohio State University College of Medicine (medical student lecture), Columbus, OH, 1/29/14

“The NICHD Neonatal Research Network: An Update,” 2014 Annual Neonatal Retreat, Nationwide Children’s Hospital, 2/12/2014

“Congenital CMV Infection: Is It Time to Screen and Treat?” Miami Children’s Hospital, Miami, FL, 2/21/2014

“Congenital CMV Infection,” 2014 Pediatric/GI Pearls Conference, Nationwide Children’s Hospital, Columbus, OH, 3/27/14

“Sífilis congénita: una oportunidad en la prevención,” “CMV: ¿cuándo y a quienes tratar?” “Herpes Neonatal: Importancia Diagnóstica y Terapéutica,” “Uso y Abuso de Antibióticos en la Unidad de Cuidados Intensivos Neonatales,” 7˚ Congreso Argentino de Infectología Pediátrica, Córdoba, Argentina., April 3-5, 2014

“Beyond Maternal Vaccination: Protecting the Preterm Infant,” Invited Symposium entitled “Immunization: Challenges and New Approaches,” Pediatric Academic Societies Meeting, Vancouver, BC, 5/6/2014

“Congenital CMV Infection: Progress and Challenges!” 2014 Perinatal/Neonatal Conference (Nationwide Children’s Hospital), Dublin, OH, 5/16/14

“Perinatal CMV Infection: Much Progress from Clinical Research, but Challenges Remain!” 26th Annual NICHD Young Investigator Conference on Maternal-Fetal-Neonatal-Reproductive Medicine, Eaglewood Resort & Spa, IL, 8/15/14

“Antibiotic Stewardship in NICU,” VIII Swan (Scott & White Annual Neonatal Conference) Conference, 9/26-27/14, Temple, TX

22

“Herpes Neonatal,” “Sepsis Neonatal Actualidades,” XV Curso Internacional de Infectología Pediátrica Cali, Colombia, 10/2/14

“Cytomegalovirus,” “Tratamento Do CMV Congȇnito: Novas Estratégias,” 18th Brazilian Congress of Pediatric Infectious Diseases, Gramado, Brazil, 10/15-16/14

“Antimicrobial Stewardship in NICU,” “Case Studies: You Be the Jury,” 11th Global Experts Meeting on Respiratory Viruses, Athens, Greece, 10/22-23/2014

“Vaccines Update: Beyond Maternal Immunization!” “Antimicrobial Stewardship in the NICU and the Changing Epidemiology of Neonatal Sepsis,” “Respiratory Viral Infections in the NICU,” The National Collaborative Perinatal Neonatal Network (NCPNN), 5th Regional Bi- Annual Meeting, Beirut, Lebanon; 11/6-8/2014

“Lues Congénita: Novedades en Diagnóstico y Tratamiento,” “Uso Racional de Antimicrobianos: Se Debe y Se Puede,” XXXI Congreso Chileno de Infectología, Puerto Varas, Chile; 11/14/2014

“Congenital and Perinatal Infections I & II,” Ohio State University College of Medicine (medical student lecture), Columbus, OH, 1/28/15

“Neonatal Sepsis I & II,” St. Rita’s Medical Center, Lima, OH, 4/17/15 and 6/19/15

“The NICHD Neonatal Research Network: An Update,” Neonatology Grand Rounds, Nationwide Children’s Hospital, Columbus, OH, 1/14/2015

“Research in Perinatal Care: Ethics and Updates,” “RSV Immunoprophylaxis,” 2015 Nationwide Children’s Hospital Perinatal/Neonatal Conference, Dublin, OH, 5/22/2015

“Uso Racional de Antibióticos en Recién Nacidos,” “Infección por CMV,” Lues Congénita,” XII Congreso Colombiano de Enfermedades Infecciosas, Bogotá, Colombia, 8/12-15/15

“Neonatal Sepsis,” Nationwide Children’s Hospital Transport Team, Columbus, OH, 8/18/15.

“Congenital CMV,” “Congenital Syphilis,” “Antimicrobial Stewardship in NICU,” 20th International Symposium on Neonatology, Sao Paolo, Brazil, 9/10-12/2105

“Congenital Syphilis,” 33rd Annual Dwight A. Powell Pediatric Infectious Diseases Conference, Nationwide Children’s Hospital, Columbus, OH, 9/17/15

“When Breast is Best: Potential Infectious Disease Benefit of Human Milk Consumption in Infants,” Meet-the-Professor Session, “Human Milk: Its Role in Infant Infection,” IDWeek, San Diego, CA, 10/7-11/15

“The Ongoing Burden of Congenital Syphilis,” (Symposium: Challenges in Perinatal Infections),

23 The World Society for Pediatric Infectious Diseases (WSPID), 9th World Congress, Rio de Janeiro, Brazil, 11/18-21/2015

“Antimicrobial Stewardship in the NICU: It’s For Our Babies!” Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Università di Milano, Milan, Italy 12/9/15

“Congenital Syphilis: The Scourge Persists!” Obstetrics & Gynecology Grand Rounds, The Ohio State University, 1/21/16

“Early-onset Sepsis,” “Congenital/Perinatal Infections,” The Ohio State University Neonatal Nurse Practitioner Student lecture, 2/23/16

“Early Onset Organisms, What Are We Treating?”, “Germ Warfare in the NICU, Who is Winning?”, “Late Onset Sepsis Organisms, Prevention and Treatment,” Angus M. McBryde Symposium: XII Dialogues in Neonatal-Perinatal Medicine, Duke University, 3/7-8/16

“Congenital CMV Infection: It’s Time to Act!”, Grand Rounds, Nationwide Children’s Hospital, Columbus, OH, 3/31/16

“The Spectrum of Cytomegalovirus: Progress and Challenges!, “Immunization in the NICU: It’s Global Health”, Neonatal Pharmacology, Las Vegas, NV, 4/14/2016

“Congenital CMV,” Infectious Diseases Society of Ohio, Columbus, OH, 4/16/16

“Estrategias para la Reducción de las Infecciones Asociadas a la Asistencia Sanitaria en el Cuidado Neonatal,: “Como Controlar el Abuso de Antibióticos en la UCI Neonatal,” “Manejo de la Corioamnionitis,” “Infecciones Perinatales y Congénitas,” Curso Internacional de Avances en Neonatología, Lima, Peru, 4/17-19/2016

“Approaches for the Early Identification of Children with Congenital Cytomegalovirus Infection,” in “Congenital Cytomegalovirus (CMV) Infection and Sensorineural Hearing Loss: Future Directions” Topic Symposium, Pediatric Academic Societies Meeting, Baltimore, MD, 5/1/16

“Chorioamnionitis-Newborn Management,” “Antimicrobial Stewardship in NICU,” Montreal Children’s Hospital, 5/5/16; “Congenital Cytomegalovirus Infection” in Neonatal Infectious Problems, Centre Mont-Royal, Montreal, Canada, 5/6/16

“Podemos restringir el uso de antibióticos en RN prematuros?”, “Impacto y Tratamiento de la Candidiasis en los Prematuros Extremos,” “Infecciónes Staphylococicas en RN: Tratamiento y Desafíos Actuales,” “Impacto de la Corioamnionitis en el RN,” VIII Curso Internacional Postgrado, Avances en Pediatria Neonatal, Concepción, Chile, 5/25-28/2016

“Hot Topics in Neonatal Infectious Diseases,” 10th Annual SWAN Conference, 9/30/16, Baylor Scott & White Health, Temple, TX

24 “Uso Racional de Antibióticos en la UCI Neonatal,” “Actualización en Infección Congénita y Adquirida por Citomegalovirus,” “Impacto de la Corioamnionitis en el RN: Manejo,” VII Congreso Chileno Neonatologia, Santiago, Chile, 10/4-7/16

“Administración de Antimicrobianos: Uso Racional,” “Sífilis Congénita,” “Citomegalovirus Congénito,” 9 Congreso Panamericano de Neonatología, Cartagena, Colombia, 10/13-15/16

“PRO: Treatment of Congenital CMV Infection,” Mano-a-Mano II Session, IDWeek, New Orleans, LA, 10/27/16; Moderator, “Curbsides in Pregnancy,: IDWeek 2017

REVIEWER – JOURNAL: Pediatric Infectious Diseases Journal Pediatrics Journal of Pediatrics New England Journal of Medicine Infection Control and Epidemiology Sexually Transmitted Diseases Journal of Perinatology Clinical Infectious Diseases American Journal of Perinatology Journal of the Pediatric Infectious Diseases Society Journal of the American Medical Association JAMA Pediatrics Pediatric Research Pediatric Neurology

GRANTS AND FUNDING: UT Southwestern: Institutional Research Support Grant, UT Southwestern Medical Center: “Molecular Analysis of the Maternal and Neonatal Immune Response to Invasive Ureaplasma urealyticum Infection”; 09/01/88 – 02/31/89, $8,000.

Principal Investigator, American Lung Association: “Improved Serodiagnosis of Ureaplasma urealyticum Infection”; 07/01/90 – 06/30/91, $17,500; 07/01/91 – 06/30/92, $17,500.

Principal Investigator, SmithKline Beecham Pharmaceuticals: “A Randomized, Double Blind, Placebo-Controlled Evaluation of the Safety, Tolerance and Efficacy of Sterile Mupirocin Calcium Ointment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization in Neonates and Infants”; 1990, $35,570.40.

Principal Investigator, Centers for Disease Control: “Diagnostic Strategies for Congenital Syphilis”, 11/01/90 – 10/31/91, $142,600.

Principal Investigator, Pediatric Aids Foundation: “Congenital Syphilis and Maternal HIV Infection”. 11/01/90 – 10/31/91, $78,000; 11/01/91 – 10/31/92, $78,000.

25

Principal Investigator, Burroughs Wellcome Co.: “Bacterial Colonization of the Respiratory Tract Following Surfactant Therapy”, 06/93 – 05/94, $32,148.

Principal Investigator, National Institutes of Health (NIAID): Molecular Strategies for Congenital Syphilis Diagnosis”, 01/01/94 – 12/31/98, $349,883.

Principal Investigator, Centers for Disease Control and Prevention: “Identifying Less Costly Strategies for Preventing Sequelae of Congenital Syphilis”, 12/01/93 – 11/30/94, $107,979; 12/01/94 – 08/31/95, $83,770.

Principal Co-Investigator, MedImmune, Inc., Gaithersburg, MD: “A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Respigam (RSV-IV) Infusions for Reduction of the Rate of RSV Hospitalization in Premature Infants and Infants with Bronchopulmonary Dysplasia”, 11/15/94 – 04/15/95, $8,538/patient (total 15-20 patients).

Principal Investigator, Pediatric Infectious Diseases Society, Fellowship Stipend from Abbott Laboratories, “Diagnosis of Congenital Syphilis”, 07/01/94 – 06/30/96, $35,000/year.

Principal Investigator, BioStar, Inc., “Performance of the Strep B OIA Test on Neonatal Urine”, 03/95, $1,160.

Principal Investigator, MedImmune, Inc., Gaithersburg, MD: “A Phase I/II, Rising, Repeated Dose, Safety, Tolerance and Pharmacokinetics Study of MEDI-493, A Humanized Monoclonal Antibody to Respiratory Syncytial Virus, Conducted in Premature Infants and Infants with Bronchopulmonary Dysplasia (Protocol #MI9CP005)”, 12/95–04/96, $8,300/ patient (total 6 patients).

Co-Investigator, SmithKline Beecham Pharmaceuticals, Conshohocken, PA: “A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple IM Doses of SB 209763 in Infants and Young Children with Predisposing Conditions as Prophylaxis Against the Development of Serious RSV Infection”, 11/95 – 04/96, $8,000/patient (total 9 patients).

Principal Investigator, NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG), “Evaluation of Ganciclovir (DHPG) for the Treatment of Symptomatic Congenital Cytomegalovirus Infection Phase III”, 12/95–1999, $3,000/patient.

Principal Investigator, NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG), “A Placebo-Controlled Phase III Evaluation of Suppressive Therapy with Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Limited to the Skin, Eye and Mouth; Phase III”, and “A Placebo-Controlled Phase III Evaluation of Suppressive Therapy with Oral Acyclovir Following Neonatal Herpes Simplex Virus Infections Involving the Central Nervous System”, 03/98 – 2007, $5000/patient.

26 Principal Investigator, Abbott Laboratories, “A Double-Blind, Placebo Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Chronic Lung Disease in Very-Low- Birth-Weight Infants Colonized with Ureaplasma urealyticum”, 1996, $50,000.

Co-Investigator, MedImmune, Inc., “A Phase I/II Study of the Safety, Tolerance and Pharmaco- kinetics of MEDI-493, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, Conducted in Otherwise Healthy Children Hospitalized with Respiratory Syncytial Virus Infection”, 3/96, $2,000.

Principal Investigator, MedImmune, Inc., “A Pivotal Phase III Study of MEDI-493, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, for the Prophylaxis of Severe RSV Disease in Premature Infants and Infants with Bronchopulmonary Dysplasia”, 10/96 – 4/97, $5,975/patient (18 patients).

Co-Investigator, MedImmune, Inc., “A Phase II Study of the Safety, Tolerance, Pharmacokinetics and Effect on Viral Load in Tracheal Aspirates of MEDI-493, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children on Mechanical Ventilation for RSV Infection”, 12/96 – 4/97, $7,404/patient.

Principal Investigator, MedImmune, Inc., “Evaluation of the Immunogenicity of IM MEDI-493 in Children Who Previously Received IM MEDI-493 Prophylaxis and Children Receiving IM MEDI-493 for the First Time”, 11/97 – 4/98, $5,613/patient (11 patients).

Principal Co-Investigator, MedImmune, Inc., “Impact of Immunoprophylaxis on RSV Hospitalization”, 1998-1999, $25,000.

Principal Co-Investigator, MedImmune, Inc., “A Phase IV Surveillance Survey of Respiratory Syncytial Virus in Hospitalized Children During Seasonal Use of Synagis (Palivizumab, MEDI-493) in the Community”, 1998 – 2002, $7,500/year.

Principal Investigator, MedImmune, Inc., “A Multicenter, Retrospective Study to Identify Selected Risk Factors for RSV Hospitalizations in Children Two Years of Age and Younger”. (1997-1999), 1999-2000, $100/patient.

Principal Investigator, NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG), “A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril (VP63843) in the Treatment of Neonates with Enteroviral Sepsis Syndrome (1999 – present) and Enteroviral Meningitis (1999 – 2000), $2000/patient.

Principal Co-Investigator, Ross Laboratories, “Elective Intubation for Single-Dose Surfactant Treatment in Neonates with Mild to Moderate RDS: A Randomized, Multicenter Trial”, UT Neonatal Clinical Research Study Group, 1999 – 2003, $100/patient.

Principal Co-Investigator, MedImmune, Inc., “A Study of the Safety, Tolerance and Efficacy of Palivizumab (MEDI-493 Synagis) for Prophylaxis of Respiratory Syncytial Virus in Children with Congenital Heart Disease”, 1999 – 2002.

27

Principal Co-Investigator, Centers for Disease Control and Prevention, “A Cost Effectiveness Analysis of Single Dose Benzathine Penicillin Versus Multiple-Dose Penicillin for the Treatment of Asymptomatic Congenital Syphilis”, 1999 – 2000, $20,000; Supplement requested for “Evidence-Based Approach to Congenital Syphilis Prevention”, 2000-2001, $22,000.

Principal Co-Investigator, MedImmune, Inc., “Palivizumab: Outcomes 1999”, and “Palivizumab: Outcome 2000”, $50/patient.

Co-Investigator, Glaxo, “Use of Valacyclovir in Late Pregnancy to Reduce Cesarean Section Delivery”, 2000-2004, $100/patient.

Principal Co-Investigator, Pediatric Academic Societies, “Practice Guideline for Management of Late-Onset Bloodstream Infections in Neonatal Intensive Care Units: Interventions to Reduce Vancomycin Use”, 2000, $2,500.

Principal Investigator, General Clinical Research Center, UT Southwestern, “Development of a Nomogram for Gentamicin Dosing in Term and Near-Term Newborns, 2000 – 2004.

Principal Investigator, MedImmune, Inc., “A Phase II, Randomized, Double-Blind, Two-Period, Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palivizumab (MEDI-493, Synagis, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, in Children with A History of Prematurity,” 11/02-4/03, $3512.50/patient (10 patients).

Principal Investigator (UTSW site) , NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG), “A Phase I/II Pharmacokinetic and Pharmacodynamic Evaluation of Oral Valganciclovir in Neonates with Symptomatic Congenital Cytomegalovirus (CMV) Infections Involving the Central Nervous System,” $12,500/patient, 7/02 – 2006.

Principal Investigator, MedImmune, Inc., “A Phase 1/2, Open-label, Repeat-Dose, Dose- Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of MEDI-524, A Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children at Risk for Serious RSV Disease (MI-CP104),” $10,075/patient (4 patients) 02/04 – 09/04.

Principal Investigator, MedImmune, Inc., “A Pivotal Phase III Study of MEDI-524 (Numax™), an Enhanced Potency Humanized Respiratory Syncytial Virus Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children (MI-CP110),” 11/04 – 5/06, $8385/patient (10 patients-2004, 15 patients-2005).

Principal Investigator (UTSWMC). “The Natural History of CMV-related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in the Newborn (CHIMES),” National Institutes of Health, National Institute on Deafness and Other Communication Disorders, RFP 260-03-19, contract N01 DC50008; $1,200,794 (2005-2014).

28

Co-Principal Investigator. “State-wide Surveillance for Respiratory Viruses and Neonatal Herpes Simplex Virus: Pediatric Epidemiology Project Proposal,” Texas Pediatric Society Foundation. $5000, 2006.

Principal Investigator (UTSWMC). “NICHD Cooperative Multicenter Neonatal Research Network,” Grant Number: 2 U10 HD040689-06, 2006-2011, $180,000; 5 U10 HD040689, 2011- 2013, $200,000

Principal Investigator (Pediatric Infectious Disease fellow, Roberto Santos). General Clinical Research Center (GCRC), UT Southwestern, “Nomogram for Gentamicin Dosing in Early Infancy,” 2005 – 2008. (Protocol #P806-10-05 USPHS Grant #M01-RR00633); Pediatric Infectious Diseases Society (PIDS) Fellowship Award - Abbott Laboratories Fellowship Award: 2006-2008 (Mentor)

Principal Co-Investigator (UTSW site), MedImmune, Inc., “Survey: RSV Prophylaxis Among Pediatric Solid Organ Transplant (SOT) Programs,” $2000, 2006-7.

Principal Investigator (UTSW site), MedImmune, Inc., “A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who Are Not Recommended to Receive Prophylaxis for RSV, 2006-7, 1500/patient (20 patients).

Principal Investigator (UTSW site), NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG), “A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Principal Investigator (UTSW), Oseltamivir (Tamiflu®) for the Treatment of Children Less than 24 Months of Age with Confirmed Influenza Infection (CASG 114, DMID #06-0059),” 2006-2010, $8500/patient.

Principal Investigator (UTSW site), Thrasher Research Fund, Influenza Vaccine Immunogenicity in Extremely Premature Infants, 2007-8, $12,568 (18 patients).

Principal Investigator (UTSW site), MedImmune, Inc., “A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against RSV in Children with Hemodynamically Significant Congenital Heart Disease, 2007-2008, $9360/patient.

Co-Investigator (UTSWMC). “NICHD Pediatric Pharmacology Research Units,” Grant Number: 5 U10 HD046000, 2007-present: A multicenter, open-label, single-arm study to evaluate the single-dose pharmacokinetics and safety of famciclovir after administration of famciclovir oral pediatric formulation to infants <1 year of age with herpes simplex or varicella zoster virus infections, $3780/patient; 2007-2009

A Phase I, Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin (FK463; Astellas) in children (2-5 Years and 6-11 Years) and Adolescents

29 (12-16 Years) With Esophageal Candidiasis or Other Invasive Candidiasis. Protocol Number: 9463-CL-2101, $14,000/patient; 2007-2011

A Phase 1, Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin (FK463; Astellas) in Infants and Toddlers (>4 months to 24 Months of Age) with Esophageal Candidiasis or Other Invasive Candidiasis, $14,900/patient; 2007-2010

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 days) with Suspected or Complicated Intra-Abdominal Infections, $3,100/patient; 2008- 2009

Antimicrobial Pharmacokinetics in High-Risk Infants. $30-227/patient, 2007-2010.

Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants <750 Grams Birth Weight, $2179/patient; 2009-2013

Pharmacokinetics of Oseltamivir During Pregnancy and Lactation, 2009-2010

Principal Investigator (UTSW site), MedImmune, Inc. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness. $10, 498/patient, 2006- 2010.

Principal Investigator (UTSW site), NIAID, Collaborative Study Performed by the Collaborative Antiviral Study Group (CASG). A Phase III Randomized, Placebo-Controlled Blinded Investigation of Six Weeks vs. Six Months of Oral Valganciclovir Therapy in Infants with Symptomatic Congenital Cytomegalovirus Infection (CASG 112; DMID # 06-0046), $14,645/patient, 2008-2013.

Principal Investigator (UTSW site), Biosynexus, Inc. A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for the Prevention of Staphylococcal Sepsis, $2288/patient, 2010-2011.

Principal Co-Investigator (UTSW site), “Controlled Trial of Live Attenuated Influenza Vaccine in Very Premature Infants – R34 AI080845. 2009-2010, $30,055

Principal Investigator (UTSW), “A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Investigational Intravenous Peramivir in Children with Influenza Disease” (CASG 117, DMID #09-0064), 2010, $14,198.60/patient

Principal Investigator (UTSW), “An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu) in the Treatment of Infants Less Than One Year of Age with Influenza Infection. F. Hoffman-La Roche Ltd. 2010-2011, $10,468.90/patient

30

An Open-Label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection. GlaxoSmithKline. 2012-2013, $20,443.44/patient

Mentor (Joseph B. Cantey, MD, UT Southwestern); Novice Researcher Award, Gerber Foundation. Use and Misuse of Antibiotic Therapy in the Neonatal Intensive Care Unit. 2012- 2014.

Nationwide Children’s Hospital/OSU: Principal Investigator (NCH/OSU). “NICHD Cooperative Multicenter Neonatal Research Network,” Grant Number: U10 HD68278, 2014-2016), $200,000/yr

Principal Investigator (NCH/OSU site), Collaborative Antiviral Study Group (University of Alabama), NIAID: 1) A Pharmacokinetic/Pharmacodynamic and Resistance Evaluation of Intravenous Ganciclovir in Premature Infants (HHSN272201100037C); 9/28/11-09/27/16; $6275/patient 2) A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children with Congenital Cytomegalovirus (CMV) Infection and Hearing Loss; 9/28/11-09/27/16; $8575/patient (pending) 3) Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by the Xpert HSV 1/2 Assay, Routine PCR, and Culture. 9/28/11-09/27/16; $132/patient (pending) 4) A Safety and Dose-determining Study of CMX001 in Infants with Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) (HHSN272201100038C); 9/28/11-09/27/16 (pending)

Principal Investigator (NCH/OSU site), MedImmune, Inc. A Phase 1b/2a Randomized, Double- Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody with an Extended Half-Life Against Respiratory Syncytial Virus, 12/2014-2016.

Co-Mentor (Christopher Ouellette, MD, Pediatric Infectious Diseases Fellow). Nationwide Children’s Hospital. Whole genome Expression Profiles of Infants with Congenital Cytomegalovirus (CMV) Infection. $10,000

Principal Investigator (NCH/OSU). “NICHD Cooperative Multicenter Neonatal Research Network,” Grant Number: 2UG1HD068278-06, 2016-2021), $200,000/yr

Principal Investigator (NCH/OSU site), MedImmune, Inc. A Phase 2b Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody with an Extended Half-Life Against Respiratory Syncytial Virus, in Healthy Preterm Infants, 11/2016-2017.

31 PEER REVIEWED PUBLICATIONS

1. Sánchez PJ, Cooper B: Candida lusitaniae: Sepsis and meningitis in a neonate. Pediatr Infect Dis J 1987;6:758-759.

2. Sánchez PJ, Regan JA: Vertical transmission of Ureaplasma urealyticum in full term infants. Pediatr Infect Dis J 1987;6:825-828.

3. Sánchez PJ, Regan JA: Ureaplasma urealyticum colonization and chronic lung disease in low-birth-weight infants. Pediatr Infect Dis J 1988;7:542-546.

4. Sánchez PJ, McCracken GH, Wendel GD, Olsen K, Threlkeld N, Norgard MV: Molecular analysis of the fetal IgM response to Treponema pallidum antigens: implications for improved serodiagnosis of congenital syphilis. J Infect Dis 1989;159:508-517.

5. Sánchez PJ, Siegel JD, Cushion N, Threlkeld N: Significance of positive urine group B streptococcal latex agglutination test in neonates. J Pediatr 1990;116:601-606.

6. Sánchez PJ, Regan JA: Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr Infect Dis J 1990;9:398-401.

7. Sánchez PJ, Siegel JD, Fishbein J: Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J 1991;10:239-243.

8. Wendel GD, Sánchez PJ, Peters MT, Harstad TW, Potter LL, Norgard MV: Identification of Treponema pallidum in amniotic fluid and fetal blood from pregnancies complicated by congenital syphilis. Obstet Gynecol 1991:78:890-895.

9. Sánchez PJ, Wendel GD, Norgard MV: Congenital syphilis associated with negative results of maternal serologic tests at delivery. Am J Dis Child 1991;145:967-969.

10. Grimprel E, Sánchez PJ, Wendel GD, Burstain JM, McCracken GH, Radolf JD, Norgard MV: Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol 1991;29:1711-1718.

11. Sánchez PJ, Wendel GD, Norgard MV: IgM antibody of Treponema pallidum in cerebrospinal fluid of infants with congenital syphilis. Am J Dis Child 1992;146:1171- 1175.

12. Mouzinho A, Rosenfeld CR, Sánchez PJ, Rosser R: Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatr 1992;90:430-435.

13. Perlman JM, Rollins N, Sánchez PJ: Late-onset meningitis in sick very-low-birth-weight infants: clinical and sonographic observations. Am J Dis Child 1992;146:1297-1301.

32 14. Sánchez PJ, Wendel GD, Grimprel E, Goldberg M, Hall M, Arencibia-Mireles O, Radolf JD, Norgard MV: Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema Pallidum. J Infect Dis 1993;167:148-157.

15. Nathan L, Twickler DM, Peters MT, Sánchez PJ, Wendel GD: Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluid. J of Ultrasound Med 1993;2:97-101.

16. Sánchez PJ: Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature. Clin Infect Dis 1993:17 (Suppl 1):S107-111.

17. Wang E, Cassell G, Sánchez PJ, Regan JA, Payne NR, Liu P: Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin Infect Dis 1993:17 (Suppl 1):S112-116.

18. Mouzinho A, Rosenfeld CR, Sánchez PJ, Risser R: Revised reference ranges for circulating neutrophils in very-low-birth-weight infants. Pediatrics 1994;94:76-82.

19. Haley RW, Cushion NB, Tenover FC, Bannerman TL, Dryer D, Ross J, Sánchez PJ, Siegel JD: Eradication of endemic methicillin-resistant staphylococcal infections from a neonatal intensive care unit. J Infect Dis 1995;171:614-624.

20. Gard JW, Starnes HM, Morrow EL, Sánchez PJ, Perlman JM: Reducing antimicrobial dosing errors in a neonatal intensive care unit. Am J Health-Syst Pharm 1995;52:1508, 1512-1513.

21. Scott LL, Sánchez PJ, Jackson GL, Zeray F, Wendel GD, Jr.: Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87:69-73.

22. Scott LL, Sánchez PJ, Jackson GL, Zeray F, Wendel GD, Jr.: Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes (letter). Obstet Gynecol 1996;87:1064-1065.

23. Palmer AL, Leos NK, Hall M, Jackson GL, Sánchez PJ: Evaluation of suprapubic bladder aspiration for detection of group B streptococcal antigen by latex agglutination in neonatal urine. Am J Perinatology 1996;13:235-239.

24. The PREVENT Study Group: Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using Respiratory Syncytial Virus Immune Globulin prophylaxis. Pediatrics 1997;99:93-99.

25. Engle WD, Rosenfeld CR, Mouzinho A, Risser RC, Zeray F, Sánchez PJ: Circulating neutrophils in septic preterm neonates: comparison of two reference ranges. Pediatrics 1997; electronic pages 99:1-6.

33 26. Nathan L, Bohman VR, Sánchez PJ, Leos NK, Twickler DM, Wendel GD: In-utero infection with Treponema pallidum in early pregnancy. Prenat Diagn 1997;17(2):119-123.

27. Sánchez PJ, Laptook AR, Fisher L, Sumner J, Perlman JM: Apnea after immunization of preterm infants. J Pediatr 1997;130:746-751.

28. Ahmed A, Cerilli LA, Sánchez PJ: Congenital malaria in a preterm neonate: case report and review of the literature. Am J Perinatology 1998;15:19-22.

29. Erbelding EJ, Vlahov D, Nelson KE, Rompalo AN, Cohn S, Sánchez P, Quinn TC, Brathwaite W, Thomas DL: Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis 1997;176:1397- 1400.

30. Subramanian KNS, Weisman LE, Rhodes T, Ariagno R, Sánchez PJ, Steichen J, Givner LB, Jennings TL, Top FH, Carlin D, Connor E: Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. Pediatr Infect Dis J 1998;17:110-115.

31. The Impact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537.

32. Saez-Llorens X, Castano E, Null D, Steichen J, Sánchez PJ, Ramilo O, Top FH, Jr., Connor E, and MEDI-493 Study Group. Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. Pediatr Infect Dis J 1998;17:787-791.

33. Malley R, DeVincenzo J, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, Sánchez PJ, Jafri H, Balsey J, Carlin D, Buckingham S, Vernacchio L, Ambrosino DM: Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1999;178:1555-1561.

34. Alexander JM, Sheffield JS, Sánchez PJ, Mayfield J, Wendel GD, Jr: Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 1999;93:5-8.

35. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sánchez PJ, Ramilo O: Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-122.

36. Benzick AE, Wirthwein DP, Weinberg A, Wendel GD, Alsaadi R, Leos NK, Zeray F, Sánchez PJ: Pituitary gland gumma in congenital syphilis after failed maternal treatment: a case report. Pediatrics 1999;104(1):e-4.

37. Malley R, Vernacchio L, DeVincenzo J, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, Jafri HS, Sánchez PJ, MacDonald K, Montana JB, Thompson CM, Ambrosino DM:

34 Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentrations and correlate results with inflammatory mediators in tracheal secretions. Pediatr Infect Dis J 2000;19:1-7.

38. Doski JJ, Lou D, Hicks BA, Megison SM, Sánchez P, Contidor M, Guzzetta PC: Management of parapneumonic collections in infants and children. J Pediatr Surg 2000;35:265-270.

39. Sorrentino M, Powers T, and The Palivizumab Outcomes Study Group: Effectiveness of Synagis (Palivizumab): evaluation of outcomes from the 1998-99 RSV season. J Pediatr Infect Dis 2000;19:1068-1071.

40. Hollier LM, Harstad TW, Sánchez PJ, Twickler DM, Wendel GD, Jr.: Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol 2001;97:947-953.

41. Scott LL, Hollier LM, McIntire D, Sánchez PJ, Jackson GL, Wendel GD, Jr: Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Infect Dis Obstet Gynecol 2001;9:75-80.

42. Sheffield JS, Sánchez PJ, Morris G, Maberry M, Zeray F, McIntire DD, Wendel GD, Jr.: Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 2002;186:569-573.

43. Wendel GD, Leveno KJ, Sánchez PJ, Jackson GL, McIntire DD, Siegel JD: Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol. Am J Obstet Gynecol 2002;186:618-626.

44. Sheffield JS, Sánchez PJ, Wendel GD, Jr., Fong DWI, Zeray F, Margraf LR, McIntire DD, Rogers BB: Placental histopathology of congenital syphilis. Obstet Gynecol 2002;100:126-133.

45. Scott LL, Hollier LM, McIntire D, Sánchez PJ, Jackson GL, Wendel GD, Jr.: Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 2002, 10:71-77.

46. Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR and the Pediatric Prevention Network. Evaluation and treatment of neonates with suspected late-onset sepsis: A survey of neonatologists' practices. Pediatrics. 2002;110(4):e42.

47. Michelow IC, Wendel GD, Jr., Norgard MV, Zeray F, Leos NK, Alsaadi R, Sánchez PJ: Central nervous system infection in congenital syphilis. N Engl J Med 2002;346:1792-1798.

48. Velaphi S, Siegel JD, Wendel GD, Jr., Cushion N, Eid WM, Sánchez PJ: Early-onset group B streptococcal infection following a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003;111:541-547.

35 49. Abzug MJ, Cloud G, Bradley J, Sánchez PJ, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberlin DW (Collaborative Antiviral Study Group). Double-blind, placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 2003;22:335-41.

50. Kimberlin DW, Lin C-Y, Sánchez PJ, Demmler GJ, Danker W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong S-J, Whitley RJ, for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group: Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr 2003;143:16-26.

51. The Texas Neonatal Research Group. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr 2004;144:804-808.

52. DeVincenzo JP, Hall CB, Kimberlin DW, Sanchez PJ, Rodriguez WJ, Jantaush BA, Corey L, Kahn JS, Englund JA, Suzich JA, Palmer-Hill FJ, Branco L, Johnson S, Patel NK, Piazza FM. Surveillance of clinical respiratory syncytial virus isolates for palivizumab (Synagis)- resistant mutants. J Infect Dis 2004;190:975-978.

53. Sáez-Llorens X, Moreno MT, Ramilo O, Sánchez PJ, Top FH Jr., Connor EM, for the MEDI -493 Study Group. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004; 23:707- 712.

54. Kapur P, Rakheja D. Gomez AM, Sheffield J, Sanchez P, Rogers BB. Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr Dev Pathol 2004; 7:453-458.

55. Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R, Demmler G, Sanchez P, Britt W, Soong S, Whitley RJ, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Detection of Cytomegalovirus (CMV) DNA by Polymerase Chain Reaction Is Associated with Hearing Loss in Newborns with Symptomatic Congenital CMV Infection Involving the Central Nervous System. J Infect Dis 2005;191:227-233.

56. Fonseca-Aten M, Messina AF, Jafri HS, Sánchez PJ. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics, 2005;115:804- 9.

57. Null D Jr., Pollara B, Dennehy PH, Steichen J, Sánchez, PJ, Givner LB, Carlin D, Landry B, Top FH Jr., Connor E. Safety and immunogenicity of palivizumab (Synagis®) administered for two seasons. Pediatr Infect Dis J, 2005; 24:1021-23.

58. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sánchez PJ, Wendel GD. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol, 2006;108(1):141-7.

36

59. Santos RP, Sánchez PJ, MD, Mejías A, Benjamin Jr. DK, Walsh TJ, Patel S, Jafri HS. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J. 2007 Apr;26(4):364-6.

60. Acosta EP, Brundage RC, King JR, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud G, Whitley R, Kimberlin DW, for the NIAID Collaborative Antiviral Study Group. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun;81(6):867-72. Epub 2007 Mar 28.

61. Ardura MI, Mejías A, Katz KS, Revell P, McCracken Jr. GH, Sánchez PJ. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Pediatr Infect Dis J. 2007 Dec;26(12):1128-32.

62. Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud GA, Lakeman FD, Whitley RJ. A pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital CMV disease. J Infect Dis 2008 Mar;197(6):836-45.

63. Stehel EK, Shoup AG, Owen KE, Jackson GL, Sendelbach DM, Boney LF, Sánchez PJ. Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics 2008 May;121(5):970-5.

64. Michaels MG, Fonseca-Aten M, Green M, Charsha-May D, Friedman B, Seikaly M, Sánchez PJ. Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant. 2008 Sep 10.

65. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, Ambalavanan N, Benjamin DK Jr; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009 Jan;123(1):58-66; PMID: 19117861

66. Santos RP, Prestidge CB, Brown ME, Urbancyzk B, Murphey DK, Salvatore CM, Jafri HS, McCracken GH Jr., Ahmad N, Sanchez PJ, Siegel JD. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis Pediatr Pulmonol. 2009 Feb;44(2):148-54.

67. Mejías A, Bustos R, Ardura MI, Ramírez C, Sánchez PJ. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J Perinatol. 2009 Apr;29(4):290-6.

37 68. Oliver SE, Cloud GA, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Soong SJ, Whitley RJ, Kimberlin DW. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virology, 2009 Dec 2009, 46S;S22–S26; PMID: 19766534

69. Benjamin Jr. DK, Smith PB, Arrieta A, Castro L, Sánchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ. Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants. Clin Pharmacol Ther. 2010 Jan;87(1):93-9. (Epub 2009 Nov 4). PMID: 19890251

70. Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Motavizumab Study Group. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010 Jan;125(1):e35- 51. (Epub 2009 Dec 14); PMID: 20008423

71. D’Angio CT, Heyne RJ, O’Shea TM, Schelonka RL, Shankaran S, Duara S, Goldberg RN, Stoll BJ, Van Meurs KP, Vohr BR, Das A, Li L, Burton RL, Hastings B, Phelps DL, Sánchez PJ, Carlo WA, Stevenson DK, Higgins RD; on behalf of the NICHD Neonatal Research Network. Heptavalent Pneumococcal Conjugate Vaccine Immunogenicity in Very-Low-Birth-Weight, Premature Infants. Pediatr Infect Dis J. 2010 Jul;29(7):600-6; PMID: 20234331

72. Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan Jr. RW, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Britt WJ, Fowler KB, for the National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Dried Blood Spot Real-Time Polymerase Chain Reaction Assays To Screen Newborns For Congenital Cytomegalovirus Infection. JAMA 2010 April; 303(14); 1375-82; PMID: 20388893

73. Duryea EL, Sánchez PJ, Sheffield JS, Jackson GL, Wendel GD, McElwee BS, Boney LF, Mallory MM, Owen KE, Stehel EK. Maternal Human Immunodeficiency Virus Infection and Congenital Transmission of Cytomegalovirus. Pediatr Infect Dis J. 2010 Oct;29(10):915-8; PMID: 20431424

74. Blumer J, Rodriguez A, Sánchez PJ, Sallas W, Kaiser G, Hamed K. Single-dose pharmaco- kinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children. Antimicrob Agents Chemother. 2010 May;54(5):2032-41. (Epub 2010 Feb 16); PMID: 20160046

75. Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Schibler K, Newman NS, Ambalavanan N, Frantz ID 3rd, Piazza AJ, Sánchez PJ, et al, on behalf of the SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. NEJM 2010;362(21):1959-69. PMID:20472937

38 76. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID 3rd, Buchter S, Sánchez PJ, et al, on behalf of the SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus Surfactant in extremely preterm infants. NEJM 2010;362(21):1970-79. PMID:20472939

77. Stoll B, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sánchez PJ, et al. Neonatal Outcomes of Extremely Preterm Infants from the NICHD Neonatal Research Network. Pediatrics 2010;126;(3):443-56. PMID:20732945

78. Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal Candidiasis: Epidemiology, risk factors, and clinical judgment. Pediatrics 2010:126(4);e865-e873. PMID:20876174

79. D'Angio CT, Heyne RJ, Duara S, Holmes LC, O’Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, Schnabel KC, Hall CB, for the Premature Infant Vaccine Collaborative. Immunogenicity of Trivalent Influenza Vaccine in extremely low-birth- weight, premature versus term infants. Pediatr Infect Dis J 2011 Jul;30(7):570-4; PMID: 21273938

80. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, et al, for the National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011 Jun 2:364(22):2111-2118. PMID: 21631323

81. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics 2011 May;127(5):817-26. PMID: 21518717

82. Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, Danthuluri VR, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Tolan RW, Palmer AL, Britt WJ, Fowler KB, Boppana SB. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis. 2011 Oct 1:204(7):1003-07. PMID: 21881114

83. Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, Palmer A, Sánchez PJ, et al, for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oral Acyclovir Suppression on Neurodevelopment After Neonatal Herpes. N Engl J Med 2011 Oct;365(14):1284-92. PMID: 21991950

39 84. Chalak LF, Rollins N, Morriss MC, Brion LP, Heyne R, Sánchez PJ. Perinatal Acidosis and Hypoxic-Ischemic Encephalopathy in Preterm Infants of 33 to 35 Weeks' Gestation. J Pediatr. 2012;160(3):388-94. PMID: 22033298

85. Lopez-Medina E, Ardura MI, Siegel JD, Brock E, Sánchez PJ. 2009 Influenza A in Infants Hospitalized at Younger than 6 Months. J Pediatr 2012;160:626-31 PMID: 22099687

86. Wynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, Stoll BJ, Shankaran S, Walsh MC, Auten KJ, Miller NA, Sánchez PJ, Higgins RD, Cotten CM, Smith PB, Benjamin DK Jr; the NICHD Neonatal Research Network. Outcomes Following Candiduria in Extremely Low Birth Weight Infants. Clin Infect Dis. 2011;54(3):331-9. PMID: 22144537

87. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, Andrews WW, Wallace D, Das A, Bell EF, Walsh MC, Laptook AR, Shankaran S, Poindexter BB, Hale EC, Newman NS, Davis AS, Schibler K, Kennedy KA, Sánchez PJ, Van Meurs KP, Goldberg RN, Watterberg KL, Faix RG, Frantz ID 3rd, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA. 2011 Dec 7;306(21):2348-58. PMID: 22147379

88. Shane AL, Hansen NI, Stoll BJ, Bell EF, Sánchez PJ, Shankaran S, Laptook AR, Das A, Walsh MC, Hale EC, Newman NS, Schrag SJ, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012 Apr;129(4):e914-22. PMID: 22412036

89. Stafford IA, Stewart RD, Sheffield JS, Wendel GD Jr, Sanchez PJ, McIntire DD, Roberts SW. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Obstet Gynecol. 2012 Jul;120(1):123-9. PMID: 22914400

90. Sood BG, Shankaran S, Schelonka RL, Saha S, Benjamin DK Jr, Sánchez PJ, Adams- Chapman I, Stoll BJ, Thorsen P, Skogstrand K, Ehrenkranz RA, Hougaard DM, Goldberg RN, Tyson JE, Das A, Higgins RD, Carlo WA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokine profiles of preterm neonates with fungal and bacterial sepsis. Pediatr Res. 2012 Aug;72(2):212-20. PMID: 22562288

91. Greenberg RG, Benjamin DK Jr, Gantz MG, Cotten CM, Stoll BJ, Walsh MC, Sánchez PJ, Shankaran S, Das A, Higgins RD, Miller NA, Auten KJ, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Ehrenkranz RA, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN, Smith PB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Empiric antifungal therapy and outcomes in

40 extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012 Aug;161(2):264-9.e2. PMID: 22424952

92. Cantey JB, Bascik SL, Heyne NG, Gonzalez JR, Jackson GL, Rogers VL, Sheffield JS, Treviño S, Sendelbach D, Wendel GD, Sánchez PJ. Prevention of mother-to-infant transmission of influenza during the postpartum period. Am J Perinatol. 2013;30(3):233-40. PMID: 22926635

93. Cantey JB, Mejías A, Wallihan R, Doern C, Brock E, Salamon D, Marcon M, Sánchez PJ. Use of Blood Polymerase Chain Reaction Testing for Diagnosis of Herpes Simplex Virus Infection. J Pediatr. 2012 Aug;161(2):357-61. PMID: 22608699

94. Pusch T, Kemp D, Trevino S, Button T, Sánchez P, Gander R, Sreeramoju P. Controlling outbreak of vancomycin-resistant Enterococcus faecium among infants caused by an endemic strain in adult inpatients. Am J Infect Control. 2013 Jan;41(1):51-6. PMID:22727513

95. Dupont TL, Chalak LF, Morriss MC, Burchfield PJ, Christie L, Sánchez PJ. Short-Term Outcomes of Newborns with Perinatal Acidemia Who are Not Eligible for Systemic Hypothermia Therapy. J Pediatr. 2013 Jan;162(1):35-41. PMID: 22871488

96. Shankaran S, Barnes PD, Hintz SR, Laptook AR, Zaterka-Baxter KM, McDonald SA, Ehrenkranz RA, Walsh MC, Tyson JE, Donovan EF, Goldberg RN, Bara R, Das A, Finer NN, Sanchez PJ, Poindexter BB, Van Meurs KP, Carlo WA, Stoll BJ, Duara S, Guillet R, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F398-404. PMID: 23080477

97. Kimberlin DW, Acosta EP, Prichard MN, Sánchez PJ, Ampofo K, Lang D, Ashouri N, Vanchiere JA, Abzug MJ, Abughali N, Caserta MT, Englund JA, Sood SK, Spigarelli MG, Bradley JS, Lew J, Michaels MG, Wan W, Cloud G, Jester P, Lakeman FD, Whitley RJ; for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years of Age with Influenza. J Infect Dis. 2013;207(5):709-20. PMID: 23230059

98. Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC, Laptook AR, Yoder BA, Faix RG, Das A, Schibler K, Rich W, Newman NS, Vohr BR, Yolton K, Heyne RJ, Wilson-Costello DE, Evans PW, Goldstein RF, Acarregui MJ, Adams-Chapman I, Pappas A, Hintz SR, Poindexter B, Dusick AM, McGowan EC, Ehrenkranz RA, Bodnar A, Bauer CR, Fuller J, O'Shea TM, Myers GJ, Higgins RD; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012 Dec 27;367(26):2495-504. PMID: 23268664

41 99. Wynn JL, Hansen NI, Das A, Cotten CM, Goldberg RN, Sánchez PJ, Bell EF, Van Meurs KP, Carlo WA, Laptook AR, Higgins RD, Benjamin DK Jr, Stoll BJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early sepsis does not increase the risk of late sepsis in very low birth weight neonates. J Pediatr. 2013;162(5):942-8. PMID: 23295144

100. Cantey JB, Sreeramoju P, Jaleel M, Treviño S, Gander R, Hynan LS, Hill J, Brown C, Chung W, Siegel JD, Sánchez PJ. Prompt control of an outbreak caused by extended- spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr. 2013;163(3):672-9. PMID: 23582136

101. Cantey JB, Pritchard MA, Sánchez PJ. Bone lesions in an infant with congenital parvovirus b19 infection. Pediatrics. 2013;131(5):e1659-63. PMID: 23610199

102. Batton B, Li L, Newman NS, Das A, Watterberg KL, Yoder BA, Faix RG, Laughon MM, Stoll BJ, Van Meurs KP, Carlo WA, Poindexter BB, Bell EF, Sánchez PJ, Ehrenkranz RA, Goldberg RN, Laptook AR, Kennedy KA, Frantz ID 3rd, Shankaran S, Schibler K, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health & Human Development Neonatal Research Network. Use of antihypotensive therapies in extremely preterm infants. Pediatrics. 2013;131(6):e1865-73. PMID: 23650301

103. Adams-Chapman I, Bann CM, Das A, Goldberg RN, Stoll BJ, Walsh MC, Sánchez PJ, Higgins RD, Shankaran S, Watterberg KL, Duara S, Miller NA, Heyne RJ, Peralta-Carcelen M, Goldstein RF, Steichen JJ, Bauer CR, Hintz SR, Evans PW, Acarregui MJ, Myers GJ, Vohr BR, Wilson-Costello DE, Pappas A, Vaucher YE, Ehrenkranz RA, McGowan EC, Dillard RG, Fuller J, Benjamin DK Jr; Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013;163(4):961-7. PMID: 23726546

104. Adams-Chapman I, Hansen NI, Shankaran S, Bell EF, Boghossian NS, Murray JC, Laptook AR, Walsh MC, Carlo WA, Sánchez PJ, Van Meurs KP, Das A, Hale EC, Newman NS, Ball MB, Higgins RD, Stoll BJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Ten-year review of major birth defects in VLBW infants. Pediatrics. 2013;132(1):49-61.PMID: 23733791

105. Oliveira CR, Guzman A, Hensely G, Leps MH, Miller NA, Sánchez PJ. Race and ethnicity of mothers with Spanish surnames. J Public Health and Epidemiology 2013;5:397-401

106. Stumpf KA, Thompson T, Sánchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics. 2013;132(3):e662-5. PMID: 23940248

107. LeVan JM, Wyckoff MH, Ahn C, Heyne R, Sánchez PJ, Chalak L, Jaleel MA, Burchfield PJ, Christie L, Soll R, Badger GJ, Brion LP. Change in care among nonenrolled patients during and after a randomized trial. Pediatrics. 2013;132(4):e960-70. PMID: 24043277

42 108. Phelps DL, Ward RM, Williams RL, Watterberg KL, Laptook AR, Wrage LA, Nolen TL, Fennell TR, Ehrenkranz RA, Poindexter BB, Michael Cotten C, Hallman MK, Frantz ID 3rd, Faix RG, Zaterka-Baxter KM, Das A, Bethany Ball M, Michael O'Shea T, Backstrom Lacy C, Walsh MC, Shankaran S, Sánchez PJ, Bell EF, Higgins RD. Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk. Pediatr Res. 2013;74(6):721-9. PMID: 24067395

109. Ronchi A, Doern C, Brock E, Pugni L, Sánchez PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr. 2014 Mar;164(3):529-35. PMID: 24359940

110. DeMauro SB, D'Agostino JA, Bann C, Bernbaum J, Gerdes M, Bell EF, Carlo WA, D'Angio CT, Das A, Higgins R, Hintz SR, Laptook AR, Natarajan G, Nelin L, Poindexter BB, Sanchez PJ, Shankaran S, Stoll BJ, Truog W, Van Meurs KP, Vohr B, Walsh MC, Kirpalani H; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Developmental outcomes of very preterm infants with tracheostomies. J Pediatr. 2014 Jun;164(6):1303-1310.e2. PMID: 24472229

111. Fernandez E, Watterberg KL, Faix RG, Yoder BA, Walsh MC, Lacy CB, Osborne KA, Das A, Kendrick DE, Stoll BJ, Poindexter BB, Laptook AR, Kennedy KA, Schibler K, Bell EF, Van Meurs KP, Frantz ID 3rd, Goldberg RN, Shankaran S, Carlo WA, Ehrenkranz RA, Sanchez PJ, Higgins RD. Incidence, Management, and Outcomes of Cardiovascular Insufficiency in Critically Ill Term and Late Preterm Newborn Infants. Am J Perinatol. 2014 Feb 10. [Epub ahead of print]; PMID: 24515617

112. Nelson DB, Lucke AM, McIntire DD, Sánchez PJ, Leveno KJ, Chalak LF. Obstetric antecedents to body-cooling treatment of the newborn infant. Am J Obstet Gynecol. 2014 Feb 13. [Epub ahead of print] PMID: 24530976

113. Chalak LF, Sánchez PJ, Adams-Huet B, Laptook AR, Heyne RJ, Rosenfeld CR. Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J Pediatr. 2014 Mar;164(3):468-74.e1. PMID: 24332821

114. Cantey JB, Sánchez PJ, Tran J, Chung W, Siegel JD. Pertussis: a persistent cause of morbidity and mortality in young infants. J Pediatr. 2014;164(6):1489-1492. PMID: 24565424

115. Rollins N, Booth T, Morriss MC, Sanchez P, Heyne R, Chalak L. Predictive value of neonatal MRI showing no or minor degrees of brain injury after hypothermia. Pediatr Neurol. 2014;50(5):447-51. PMID: 24656462

116. Oliveira CR, Morriss MC, Mistrot JG, Cantey JB, Doern CD, Sánchez PJ. Brain Magnetic Resonance Imaging of Infants with Bacterial Meningitis. J Pediatr. 2014;165:134-9. PMID: 24726712

43 117. Chalak LF, Dupont TL, Sánchez PJ, Lucke A, Heyne RJ, Morriss MC, Rollins NK. Neurodevelopmental outcomes after hypothermia therapy in the era of Bayley-III. J Perinatol. 2014 Apr 17 [Epub ahead of print] PMID:24743133

118. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sánchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Fowler KB, Boppana SB; for the National Institute on Deafness and Other Communication Disorders CHIMES Study. Detection of Congenital Cytomegalovirus Infection by Real-Time Polymerase Chain Reaction of Saliva or Urine. J Infect Dis. 2014 May 5. [Epub ahead of print] PMID: 24799600

119. Kamal M, Acosta E, Kimberlin D, Gibiansky L, Jester P, Niranjan V, Rath B, Clinch B, Sánchez P, Ampofo K, Whitley R, Rayner C. The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach. Clin Pharmacol Ther. 2014 May 27. (Epub ahead of print). PMID: 24865390

120. LeVan JM, Brion LP, Wrage LA, Gantz MG, Wyckoff MH, Sánchez PJ, Heyne R, Jaleel M, Finer NN, Carlo WA, Das A, Stoll BJ, Higgins RD; on behalf of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Bethesda, MD. Change in practice after the Surfactant, Positive Pressure and Oxygenation Randomised Trial. Arch Dis Child Fetal Neonatal Ed 2014; May 29, 2014 (Epub ahead of print). PMID: 24876196

121. Notario G, Vo P, Gooch K, Deaton R, Wu X, Harris B, Mahadevia PJ, Sanchez PJ. Respiratory syncytial virus-related hospitalization in premature infants without bronchopulmonary dysplasia: a subgroup efficacy analysis of the IMpact-RSV trial by gestational age group. Pediatric Health, Medicine and Therapeutics, May 30, 2014:5; 43 – 48.

122. Morriss FH Jr, Saha S, Bell EF, Colaizy TT, Stoll BJ, Hintz SR, Shankaran S, Vohr BR, Hamrick SE, Pappas A, Jones PM, Carlo WA, Laptook AR, Van Meurs KP, Sánchez PJ, Hale EC, Newman NS, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Surgery and neurodevelopmental outcome of very low-birth-weight infants. JAMA Pediatr. 2014;168(8):746-54. PMID:24934607

123. Ronchi A, Michelow IC, Chapin KC, Bliss JM, Pugni L, Mosca F, Sánchez PJ. Viral Respiratory Tract Infections in the Neonatal Intensive Care Unit: The VIRIoN-I Study. J Pediatr. 2014 Jul 12. PMID: 25027362

124. Truog WE, Nelin LD, Das A, Kendrick DE, Bell EF, Carlo WA, Higgins RD, Laptook AR, Sanchez PJ, Shankaran S, Stoll BJ, Van Meurs KP, Walsh MC; NICHD Neonatal Research Network. Inhaled nitric oxide usage in preterm infants in the NICHD Neonatal Research Network: inter-site variation and propensity evaluation. J Perinatol. 2014;34(11):842-6. PMID:24901452

44 125. Anyebuno M, Lopez-Medina E, Sánchez PJ. Prolonged maternal postpartum fever and neonatal herpes infection. J Perinatol. 2014; 34:716–717.

126. De Jesus LC, Sood BG, Shankaran S, Kendrick D, Das A, Bell EF, Stoll BJ, Laptook AR, Walsh MC, Carlo WA, Sanchez PJ, Van Meurs KP, Bara R, Hale EC, Newman NS, Ball MB, Higgins RD; Eunice Kennedy Shriver National Institute of Health and Human Development Neonatal Research Network. Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants. Am J Obstet Gynecol. 2015;212(1):94. PMID:25046806

127. Abzug MJ, Michaels MG, Wald E, Jacobs RF, Romero JR, Sanchez PJ, Wilson G, Krogstad P, Storch GA, Lawrence R, Shelton M, Palmer A, Robinson J, Dennehy P, Sood SK, Cloud G, Jester P, Acosta EP, Whitley R, Kimberlin D. A Randomized, Double-Blind, Placebo- Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis. J Ped Infect Dis Soc. 2016;5:53-62. PMID: 26407253

128. Cantey JB, Wozniak PS, Sánchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J. 2015 Mar;34(3):267-72. PMID:25191849

129. Sood BG, Keszler M, Garg M, Klein JM, Ohls R, Ambalavanan N, Cotten CM, Malian M, Sanchez PJ, Lakshminrusimha S, Nelin LD, Van Meurs KP, Bara R, Saha S, Das A, Wallace D, Higgins RD, Shankaran S. Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials. Trials. 2014 Dec 12;15(1):486. PMID:25496504

130. Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR, Sánchez PJ, Shankaran S, Van Meurs KP, Ball MB, Hale EC, Newman NS, Das A, Higgins RD, Stoll BJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med. 2015 Jan 22;372(4):331-40. PMID:25607427

131. Cantey JB, Klein AM, Sánchez PJ. Herpes Simplex Virus DNAemia Preceding Neonatal Disease. J Pediatr. 2015 May;166(5):1308-9. PMID:25720363

132. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015 Mar 5;372(10):933-43. PMID:25738669

45 133. Clayton JT, Reisch JS, Sanchez PJ, Fickes JL, Portillo CM, Chen LE. Postoperative Regimentation Of Treatment Optimizes Care and Optimizes Length of Stay (PROTOCOL) after pyloromyotomy. J Pediatr Surg. 2014 Dec 31. PMID:25783325

134. Fernandez E, Watterberg KL, Faix RG, Yoder BA, Walsh MC, Lacy CB, Osborne KA, Das A, Kendrick DE, Stoll BJ, Poindexter BB, Laptook AR, Kennedy KA, Schibler K, Bell EF, Van Meurs KP, Frantz ID 3rd, Goldberg RN, Shankaran S, Carlo WA, Ehrenkranz RA, Sánchez PJ, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Definitions of Cardiovascular Insufficiency and Relation to Outcomes in Critically Ill Newborn Infants. Am J Perinatol. 2015 Mar 31. PMID:25825962

135. Lopez-Medina E, Cantey JB, Sánchez PJ. The mortality of neonatal herpes simplex virus infection. J Pediatr. 2015 Jun;166(6):1529-32. PMID:25868428

136. Pinninti SG, Ross SA, Shimamura M, Novak Z, Palmer AL, Ahmed A, Tolan RW Jr, Bernstein DI, Michaels MG, Sánchez PJ, Fowler KB, Boppana SB; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection. Pediatr Infect Dis J. 2015 May;34(5):536-7. PMID: 25876092

137. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sánchez PJ, Stewart A, Bernstein DI, Feja K, Novak Z, Fowler KB, Boppana SB; National Institute on Deafness and Other Communication Disorders CHIMES Study. Urine Collection Method for the Diagnosis of Congenital Cytomegalovirus Infection. Pediatr Infect Dis J. 2015 May 9. PMID:25973993

138. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, Van Meurs KP, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D'Angio CT, DeMauro SB, Truog WE, Devaskar U, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA. 2015;314(10):1039-51. PMID: 26348753

139. Wortham JM, Hansen NI, Schrag SJ, Hale E, Van Meurs K, Sánchez PJ, Cantey JB, Faix R, Poindexter B, Goldberg R, Bizzarro M, Frantz I, Das A, Benitz WE, Shane AL, Higgins R, Stoll BJ; Eunice Kennedy Shriver NICHD Neonatal Research Network. Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections. Pediatrics. 2016;137(1). PMID: 26719293

140. Watson JR, Sánchez PJ, Spencer JD, Cohen DM, Hains DS. Urinary Tract Infection and Antimicrobial Stewardship in the Emergency Department. Pediatr Emerg Care. 2016 Feb 6. [Epub ahead of print] PMID: 26855344

46 141. Vicetti Miguel CP, Mejias A, Ramilo O, Ardura MI, Sánchez PJ. Cytomegalovirus Meningitis in an Infant with Severe Combined Immunodeficiency. J Pediatr. 2016; 173:235-7. PMID: 26996725

142. Phelps DL, Ward RM, Williams RL, Nolen TL, Watterberg KL, Oh W, Goedecke M, Ehrenkranz RA, Fennell T, Poindexter BB, Cotten CM, Hallman M, Frantz ID 3rd, Faix RG, Zaterka-Baxter KM, Das A, Ball MB, Lacy CB, Walsh MC, Carlo WA, Sánchez PJ, Bell EF, Shankaran S, Carlton DP, Chess PR, Higgins RD. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res. 2016 Jun 8. doi: 10.1038/pr.2016.97. [Epub ahead of print] PMID: 27074126

143. Navarrete CT, Wrage LA, Carlo WA, Walsh MC, Rich W, Gantz MG, Das A, Schibler K, Newman NS, Piazza AJ, Poindexter BB, Shankaran S, Sánchez PJ, Morris BH, Frantz ID 3rd, Van Meurs KP, Cotten CM, Ehrenkranz RA, Bell EF, Watterberg KL, Higgins RD, Duara S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth. J Pediatr. 2016 Sep;176:62-68. PMID: 27344218

144. Archer SW, Carlo WA, Truog WE, Stevenson DK, Van Meurs KP, Sánchez PJ, Das A, Devaskar U, Nelin LD, Petrie Huitema CM, Crawford MM, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Improving publication rates in a collaborative clinical trials research network. Semin Perinatol. 2016 Jul 13. PMID: 27423510

145. Cantey JB, Wozniak PS, Pruszynski JE, Sánchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016 Oct;16(10):1178-84. PMID: 27452782

146. Rajah B, Sánchez PJ, Garcia-Maurino C, Leber A, Ramilo O, Mejias A. Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience. J Pediatr. 2016 Nov 15;(16)31208-2. [Epub ahead of print]. PMID: 27855996

147. Moallem M, Song E, Jaggi P, Conces MR, Kajon AE, Sánchez PJ. Adenovirus and "Culture-Negative Sepsis" in a Preterm Neonate. AJP Rep. 2016 Oct;6(4):e417-e420. PMID: 27924246

148. Archer SW, Carlo WA, Truog WE, Stevenson DK, Van Meurs KP, Sánchez PJ, Das A, Devaskar U, Nelin LD, Petrie Huitema CM, Crawford MM, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Improving publication rates in a collaborative clinical trials research network. Semin Perinatol. 2016 Oct;40(6):410-417. PMID: 27423510

47 149. Navarrete CT, Wrage LA, Carlo WA, Walsh MC, Rich W, Gantz MG, Das A, Schibler K, Newman NS, Piazza AJ, Poindexter BB, Shankaran S, Sánchez PJ, Morris BH, Frantz ID 3rd, Van Meurs KP, Cotten CM, Ehrenkranz RA, Bell EF, Watterberg KL, Higgins RD, Duara S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth. J Pediatr. 2016 Sep;176:62- 68.e4. PMID: 27344218

150. Phelps DL, Ward RM, Williams RL, Nolen TL, Watterberg KL, Oh W, Goedecke M, Ehrenkranz RA, Fennell T, Poindexter BB, Cotten CM, Hallman M, Frantz ID 3rd, Faix RG, Zaterka-Baxter KM, Das A, Ball MB, Lacy CB, Walsh MC, Carlo WA, Sánchez PJ, Bell EF, Shankaran S, Carlton DP, Chess PR, Higgins RD. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res. 2016 Aug;80(2):209-17. PMID: 27074126

CORPORATE AUTHORSHIP IN MULTICENTER TRIALS

1. Oh W, Stevenson DK, Tyson JE, Morris BH, Ahlfors CE, Bender GJ, Wong RJ, Perritt R, Vohr BR, Van Meurs KP, Vreman HJ, Das A, Phelps DL, O'Shea TM, Higgins RD; NICHD Neonatal Research Network Bethesda MD. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr. 2010 May;99(5):673-8. Erratum in: Acta Paediatr. 2013 Mar;102(3):326. PMID: 20105142

2. Davis AS, Hintz SR, Van Meurs KP, Li L, Das A, Stoll BJ, Walsh MC, Pappas A, Bell EF, Laptook AR, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Seizures in extremely low birth weight infants are associated with adverse outcome. J Pediatr. 2010 Nov;157(5):720-5. PMID: 20542294

3. Rich WD, Auten KJ, Gantz MG, Hale EC, Hensman AM, Newman NS, Finer NN; National Institute of Child Health and Human Development Neonatal Research Network. Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment. Pediatrics. 2010 Jul;126(1):e215-21. PMID: 20587676

4. Boghossian NS, Hansen NI, Bell EF, Stoll BJ, Murray JC, Laptook AR, Shankaran S, Walsh MC, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Survival and morbidity outcomes for very low birth weight infants with Down syndrome. Pediatrics. 2010 Dec;126(6):1132- 40. PMID: 21098157

5. Ang JY, Lua JL, Asmar BI, Shankaran S, Heyne RJ, Schelonka RL, Das A, Li L, Jackson DM, Higgins RD, D'Angio CT; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Nasopharyngeal carriage of Streptococcus pneumoniae in very low-birth-weight infants after administration of

48 heptavalent pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med. 2010 Dec;164(12):1173-5. PMID: 21135351

6. Pappas A, Shankaran S, Laptook AR, Langer JC, Bara R, Ehrenkranz RA, Goldberg RN, Das A, Higgins RD, Tyson JE, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2011 May;158(5):752-758. PMID: 21146184

7. Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, Stoll BJ, Buchter S, Laptook AR, Ehrenkranz RA, Cotten CM, Wilson-Costello DE, Shankaran S, Van Meurs KP, Davis AS, Gantz MG, Finer NN, Yoder BA, Faix RG, Carlo WA, Schibler KR, Newman NS, Rich W, Das A, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. PMID: 21471086

8. Shankaran S, Pappas A, McDonald SA, Laptook AR, Bara R, Ehrenkranz RA, Tyson JE, Goldberg R, Donovan EF, Fanaroff AA, Das A, Poole WK, Walsh M, Higgins RD, Welsh C, Salhab W, Carlo WA, Poindexter B, Stoll BJ, Guillet R, Finer NN, Stevenson DK, Bauer CR; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Predictive value of an early amplitude integrated electroencephalogram and neurologic examination.Pediatrics. 2011 Jul;128(1):e112-20. PMID: 21669899 [

9. Cole CR, Hansen NI, Higgins RD, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Das A, Stoll BJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development’s Neonatal Research Network. Bloodstream infections in very low birth weight infants with intestinal failure. J Pediatr. 2012 Jan;160(1):54-9. PMID: 21840538

10. Wyckoff MH, Salhab WA, Heyne RJ, Kendrick DE, Stoll BJ, Laptook AR; National Institute of Child Health and Human Development Neonatal Research Network. Outcome of extremely low birth weight infants who received delivery room cardiopulmonary resuscitation. J Pediatr. 2012 Feb;160(2):239-244. PMID: 21930284

11. Sant'Anna G, Laptook AR, Shankaran S, Bara R, McDonald SA, Higgins RD, Tyson JE, Ehrenkranz RA, Das A, Goldberg RN, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Phenobarbital and temperature profile during hypothermia for hypoxic-ischemic encephalopathy. J Child Neurol. 2012 Apr;27(4):451-7. PMID: 21960671

12. Ambalavanan N, Carlo WA, McDonald SA, Yao Q, Das A, Higgins RD; Generic Database and Follow-up Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Identification of extremely

49 premature infants at high risk of rehospitalization. Pediatrics. 2011 Nov;128(5):e1216-25. PMID: 22007016 [

13. Rich W, Finer NN, Gantz MG, Newman NS, Hensman AM, Hale EC, Auten KJ, Schibler K, Faix RG, Laptook AR, Yoder BA, Das A, Shankaran S; SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics. 2012 Mar;129(3):480-4. PMID: 22371462

14. De Jesus LC, Pappas A, Shankaran S, Kendrick D, Das A, Higgins RD, Bell EF, Stoll BJ, Laptook AR, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants. J Pediatr. 2012 Jul;161(1):70-4. PMID: 22325187

15. Duncan AF, Watterberg KL, Nolen TL, Vohr BR, Adams-Chapman I, Das A, Lowe J; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Effect of ethnicity and race on cognitive and language testing at age 18-22 months in extremely preterm infants. J Pediatr. 2012 Jun;160(6):966-71. PMID: 22269248

16. Vohr BR, Stephens BE, Higgins RD, Bann CM, Hintz SR, Das A, Newman JE, Peralta- Carcelen M, Yolton K, Dusick AM, Evans PW, Goldstein RF, Ehrenkranz RA, Pappas A, Adams-Chapman I, Wilson-Costello DE, Bauer CR, Bodnar A, Heyne RJ, Vaucher YE, Dillard RG, Acarregui MJ, McGowan EC, Myers GJ, Fuller J; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes. J Pediatr. 2012 Aug;161(2):222-8.PMID: 22421261

17. Smith PB, Ambalavanan N, Li L, Cotten CM, Laughon M, Walsh MC, Das A, Bell EF, Carlo WA, Stoll BJ, Shankaran S, Laptook AR, Higgins RD, Goldberg RN; Generic Database Subcommittee; Eunice Kennedy Shriver National Institute of Child Health Human Development Neonatal Research Network. Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants. Pediatrics. 2012 Jun;129(6):e1508-16. PMID: 22641761

18. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, Gustafson KE, Leach TM, Green C, Bara R, Petrie Huitema CM, Ehrenkranz RA, Tyson JE, Das A, Hammond J, Peralta-Carcelen M, Evans PW, Heyne RJ, Wilson-Costello DE, Vaucher YE, Bauer CR, Dusick AM, Adams-Chapman I, Goldstein RF, Guillet R, Papile LA, Higgins RD; Eunice Kennedy Shriver NICHD Neonatal Research Network. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012 May 31;366(22):2085- 92. Erratum in: N Engl J Med. 2012 Sep 13;367(11):1073. PMID: 22646631

50 19. Newman JE, Bann CM, Vohr BR, Dusick AM, Higgins RD; Follow-Up Study Group of Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Improving the Neonatal Research Network annual certification for neurologic examination of the 18-22 month child. J Pediatr. 2012;161(6):1041-6. PMID: 22748517

20. Boghossian NS, Page GP, Bell EF, Stoll BJ, Murray JC, Cotten CM, Shankaran S, Walsh MC, Laptook AR, Newman NS, Hale EC, McDonald SA, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr. 2013;162(6):1120-4. PMID: 23324523

21. De Jesus LC, Pappas A, Shankaran S, Li L, Das A, Bell EF, Stoll BJ, Laptook AR, Walsh MC, Hale EC, Newman NS, Bara R, Higgins RD; Eunice Kennedy Shriver National Institute of Health and Human Development Neonatal Research Network. Outcomes of small for gestational age infants born at <27 weeks' gestation. J Pediatr. 2013;163(1):55-60. PMID: 23415614

22. Adams-Chapman I, Bann CM, Vaucher YE, Stoll BJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association between feeding difficulties and language delay in preterm infants using Bayley Scales of Infant Development-Third Edition. J Pediatr. 2013;163(3):680-5. PMID: 23582139

23. Laptook AR, McDonald SA, Shankaran S, Stephens BE, Vohr BR, Guillet R, Higgins RD, Das A; Extended Hypothermia Follow‐up Subcommittee of the National Institute of Child Health and Human Development Neonatal Research Network. Elevated temperature and 6- to 7-year outcome of neonatal encephalopathy. Ann Neurol. 2013 ;73(4):520-8. PMID: 23595408

24. Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, Ross S, Boppana S; NIDCD CHIMES Study Investigators. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J. 2013;32(10):1050-4. PMID: 23694837

25. Alleman BW, Bell EF, Li L, Dagle JM, Smith PB, Ambalavanan N, Laughon MM, Stoll BJ, Goldberg RN, Carlo WA, Murray JC, Cotten CM, Shankaran S, Walsh MC, Laptook AR, Ellsbury DL, Hale EC, Newman NS, Wallace DD, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Individual and center-level factors affecting mortality among extremely low birth weight infants. Pediatrics. 2013;132(1):e175-84. PMID: 23753096

26. Natarajan G, Shankaran S, Laptook AR, Pappas A, Bann CM, McDonald SA, Das A, Higgins RD, Hintz SR, Vohr BR; Extended Hypothermia Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Apgar scores at 10 min and outcomes at 6-7 years following hypoxic-

51 ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2013;98(6):F473-9. PMID: 23896791

27. Stark AR, Carlo WA, Vohr BR, Papile LA, Saha S, Bauer CR, Oh W, Shankaran S, Tyson JE, Wright LL, Poole WK, Das A, Stoll BJ, Fanaroff AA, Korones SB, Ehrenkranz RA, Stevenson DK, Peralta-Carcelen M, Wilson-Costello DE, Bada HS, Heyne RJ, Johnson YR, Lee KG, Steichen JJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants. J Pediatr. 2014;164(1):34-39.e2. PMID: 23992673

28. Vohr BR, Stephens BE, McDonald SA, Ehrenkranz RA, Laptook AR, Pappas A, Hintz SR, Shankaran S, Higgins RD, Das A; Extended Hypothermia Follow-up Subcommittee of the NICHD Neonatal Research Network. Cerebral palsy and growth failure at 6 to 7 years. Pediatrics. 2013;132(4):e905-14. PMID: 24019415

29. Wadhawan R1, Oh W1, Hintz SR2, Blakely ML3, Das A4, Bell EF5, Saha S6, Laptook AR1, Shankaran S7, Stoll BJ8, Walsh MC9, Higgins RD10; NICHD Neonatal Research Network. Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. J Perinatol. 2014;34(1):64-70. PMID: 24135709

30. Cotten CM, Goldstein RF, McDonald SA, Goldberg RN, Salhab WA, Carlo WA, Tyson JE, Finer NN, Walsh MC, Ehrenkranz RA, Laptook AR, Guillet R, Schibler K, Van Meurs KP, Poindexter BB, Stoll BJ, O'Shea TM, Duara S, Das A, Higgins RD, Shankaran S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Apolipoprotein E genotype and outcome in infants with hypoxic- ischemic encephalopathy. Pediatr Res. 2014 Mar;75(3):424-30. PMID: 24322171

31. Boghossian NS, Hansen NI, Bell EF, Stoll BJ, Murray JC, Carey JC, Adams-Chapman I, Shankaran S, Walsh MC, Laptook AR, Faix RG, Newman NS, Hale EC, Das A, Wilson LD, Hensman AM, Grisby C, Collins MV, Vasil DM, Finkle J, Maffett D, Ball MB, Lacy CB, Bara R, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18. Pediatrics. 2014 Feb;133(2):226-35. PMID: 24446439

32. Kennedy KA, Wrage LA, Higgins RD, Finer NN, Carlo WA, Walsh MC, Laptook AR, Faix RG, Yoder BA, Schibler K, Gantz MG, Das A, Newman NS, Phelps DL; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infants. J Perinatol. 2014 Apr;34(4):311-8. Epub 2014 Feb 6. PMID: 24503911

52 33. Benjamin DK Jr, Hudak ML, Duara S, Randolph DA, Bidegain M, Mundakel GT, Natarajan G, Burchfield DJ, White RD, Shattuck KE, Neu N, Bendel CM, Kim MR, Finer NN, Stewart DL, Arrieta AC, Wade KC, Kaufman DA, Manzoni P, Prather KO, Testoni D, Berezny KY, Smith PB; Fluconazole Prophylaxis Study Team. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA. 2014;311(17):1742-9. PMID: 24794367

34. Randolph DA, Nolen TL, Ambalavanan N, Carlo WA, Peralta-Carcelen M, Das A, Bell EF, Davis AS, Laptook AR, Stoll BJ, Shankaran S, Higgins RD; Generic Database and Follow- Up Subcommittees for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Outcomes of extremely low birthweight infants with acidosis at birth.Arch Dis Child Fetal Neonatal Ed. 2014 Jul;99(4):F263-8. PMID:24554564

35. D'Angio CT, Murray TE, Li L, Heyne RJ, O'Shea TM, Schelonka RL, Shankaran S, Duara S, Goldberg RN, Stoll BJ, Stevenson DK, Vohr BR, Phelps DL, Carlo WA, Pichichero ME, Das A, Higgins RD; NICHD Neonatal Research Network. Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants. Pediatr Infect Dis J. 2013; 32(12):1400-2. PMID: 24569312

36. Stevens TP, Finer NN, Carlo WA, Szilagyi PG, Phelps DL, Walsh MC, Gantz MG, Laptook AR, Yoder BA, Faix RG, Newman JE, Das A, Do BT, Schibler K, Rich W, Newman NS, Ehrenkranz RA, Peralta-Carcelen M, Vohr BR, Wilson-Costello DE, Yolton K, Heyne RJ, Evans PW, Vaucher YE, Adams-Chapman I, McGowan EC, Bodnar A, Pappas A, Hintz SR, Acarregui MJ, Fuller J, Goldstein RF, Bauer CR, O'Shea TM, Myers GJ, Higgins RD; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr. 2014 Aug;165(2):240-249. PMID:24725582

37. Natarajan G, Shankaran S, Pappas A, Bann C, Tyson JE, McDonald S, Das A, Hintz S, Vohr B, Higgins R; Extended Hypothermia Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Functional status at 18 months of age as a predictor of childhood disability after neonatal hypoxic-ischemic encephalopathy.Dev Med Child Neurol. 2014 Nov;56(11):1052-8. PMID:24957482

38. Laptook AR, Kilbride H, Shepherd E, McDonald SA, Shankaran S, Truog W, Das A, Higgins RD; Optimizing Cooling Sub-Committee. Temperature control during therapeutic hypothermia for newborn encephalopathy using different Blanketrol devices. Ther Hypothermia Temp Manag. 2014 Dec;4(4):193-200. PMID:25285767

39. Kelleher J, Salas AA, Bhat R, Ambalavanan N, Saha S, Stoll BJ, Bell EF, Walsh MC, Laptook AR, Sánchez PJ, Shankaran S, VanMeurs KP, Hale EC, Newman NS, Ball MB, Das A, Higgins RD, Peralta-Carcelen M, Carlo WA; GDB Subcommittee, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research

53 Network. Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants. Pediatrics. 2014 Nov;134(5):e1369-77.

40. Ambalavanan N, Carlo WA, Wrage LA, Das A, Laughon M, Cotten CM, Kennedy KA, Laptook AR, Shankaran S, Walsh MC, Higgins RD; SUPPORT Study Group of the NICHD Neonatal Research Network. PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT). Arch Dis Child Fetal Neonatal Ed. 2015 Mar;100(2):F145-9. PMID:25425651

41. Ambalavanan N, Cotten CM, Page GP, Carlo WA, Murray JC, Bhattacharya S, Mariani TJ, Cuna AC, Faye-Petersen OM, Kelly D, Higgins RD; Genomics and Cytokine Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr. 2015 Mar;166(3):531-7. PMID:25449221

42. Davis AS, Gantz MG, Do B, Shankaran S, Hamrick SE, Kennedy KA, Tyson JE, Chalak LF, Laptook AR, Goldstein RF, Hintz SR, Das A, Higgins RD, Ball MB, Hale EC, Van Meurs KP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Serial aEEG recordings in a cohort of extremely preterm infants: feasibility and safety. J Perinatol. 2015 May;35(5):373-8. PMID:25474559

43. Shankaran S, Laptook AR, Pappas A, McDonald SA, Das A, Tyson JE, Poindexter BB, Schibler K, Bell EF, Heyne RJ, Pedroza C, Bara R, Van Meurs KP, Grisby C, Huitema CM, Garg M, Ehrenkranz RA, Shepherd EG, Chalak LF, Hamrick SE, Khan AM, Reynolds AM, Laughon MM, Truog WE, Dysart KC, Carlo WA, Walsh MC, Watterberg KL, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA. 2014;312(24):2629-39. PMID:25536254

44. Hintz SR, Barnes PD, Bulas D, Slovis TL, Finer NN, Wrage LA, Das A, Tyson JE, Stevenson DK, Carlo WA, Walsh MC, Laptook AR, Yoder BA, Van Meurs KP, Faix RG, Rich W, Newman NS, Cheng H, Heyne RJ, Vohr BR, Acarregui MJ, Vaucher YE, Pappas A, Peralta-Carcelen M, Wilson-Costello DE, Evans PW, Goldstein RF, Myers GJ, Poindexter BB, McGowan EC, Adams-Chapman I, Fuller J, Higgins RD; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neuroimaging and neurodevelopmental outcome in extremely preterm infants. Pediatrics. 2015 Jan;135(1):e32-42. doi: 10.1542/peds.2014- 0898. Epub 2014 Dec 1.PMID:25554820

45. Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA, Tyson JE, Yolton K, Das A, Bara R, Hammond J, Higgins RD; Hypothermia Extended Follow-up Subcommittee of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Cognitive outcomes after neonatal encephalopathy. Pediatrics. 2015 Mar;135(3):e624-34. PMID:25713280

54 46. Hoffman L, Bann C, Higgins R, Vohr B; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Developmental outcomes of extremely preterm infants born to adolescent mothers. Pediatrics. 2015;135(6):1082-92. PMID:25963007

47. Ment LR, Ådén U, Bauer CR, Bada HS, Carlo WA, Kaiser JR, Lin A, Cotten CM, Murray J, Page G, Hallman M, Lifton RP, Zhang H; Gene Targets for IVH Study Group and the Neonatal Research Network. Genes and environment in neonatal intraventricular hemorrhage.Semin Perinatol. 2015 Dec;39(8):592-603. PMID: 26516117

48. Ericson JE, Kaufman DA, Kicklighter SD, Bhatia J, Testoni D, Gao J, Smith PB, Prather KO, Benjamin DK Jr; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data. Clin Infect Dis. 2016 Sep 1;63(5):604-10. PMID: 27298330

49. Ment LR, Ådén U, Bauer CR, Bada HS, Carlo WA, Kaiser JR, Lin A, Cotten CM, Murray J, Page G, Hallman M, Lifton RP, Zhang H; Gene Targets for IVH Study Group and the Neonatal Research Network. Genes and environment in neonatal intraventricular hemorrhage. Semin Perinatol. 2015 Dec;39(8):592-603. Review. PMID: 26516117

CORPORATE AUTHORSHIP - NATIONAL COMMITTEES

1. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV- exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. PMID: 19730409

2. Sexually Transmitted Diseases Treatment Guidelines (Congenital Syphilis). MMWR Recomm Rep 2015;64(No. RR-3:45-49.

3. Russell K, Oliver SE, Lewis L, Barfield WD, Cragan J, Meaney-Delman D, Staples JE, Fischer M, Peacock G, Oduyebo T, Petersen EE, Zaki S, Moore CA, Rasmussen SA; Contributors. Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):870-878. PMID: 27559830

INVITED EDITORIALS:

55

1. Mejías A, Sánchez PJ. Update on cytomegalovirus. An Pediatr (Barc). 2009 Jun;70(6):517-8. Spanish. PMID: 19446507

2. Cantey JB, Sánchez PJ. Prolonged antibiotic therapy for "culture-negative" sepsis in preterm infants: it's time to stop! J Pediatr. 2011 Nov;159(5):707-8. Epub 2011 Aug 31. PMID: 21885065

3. Mejias A, Ramilo O, Sánchez PJ. [Testing for respiratory viruses in the neonatal intensive care unit: Ready for prime time?].An Pediatr (Barc). 2015 Jun;82(6):378-80 (Spanish). PMID:25936495

4. Cantey JB, Ronchi A, Sanchez PJ. Spreading the Benefits of Infection Prevention in the Neonatal Intensive Care Unit." JAMA Pediatr. 2015;169(12):1089-91. PMID: 26501886

5. Sánchez PJ, Moallem M, Cantey JB, Milton A, Michelow IC. Empiric Therapy with Vancomycin in the Neonatal Intensive Care Unit: Let’s “Get Smart” Globally! Jornal de Pediatria. 2016; 92, issue 5, September/October 2016. PMID: 27343632

6. Cooper JM, Michelow IC, Wozniak PS, Sánchez PJ. In Time: The Persistence of Congenital Syphilis in Brazil - More Progress Needed! Rev Paul Pediatr. 2016;34(3):251-253. PMID: 27521453

LETTER TO THE EDITOR:

1. Sendelbach DM, Sanchez PJ. Varicella, influenza: not necessary to separate mother and infant. Pediatrics. 2012 Aug;130(2):e464. PMID: 22855925

BOOK CHAPTERS AND REVIEWS:

1. Sánchez PJ: Nosocomial infections in the nursery. In: Nelson, JD (ed). Current Therapy in Pediatric Infectious Disease. 2nd Edition, Philadelphia; 1988, pp. 307-312.

2. Sánchez PJ, Siegel JD: Congenital and perinatal infections: Cytomegalovirus, Herpes simplex virus, Syphilis, Hepatitis viruses, Neisseria gonorrhoeae, Chlamydia trachomatis, Genital mycoplasmas. In: Oski FA, DeAngelis C, Feigin RD, Warshaw JB, Jones MD Jr., McMillan J (eds). Oski’s Pediatrics: Principles and Practice. 1st Edition, Philadelphia; 1990, pp. 494-514; 2nd Edition, 1994, pp. 540-561; 3rd Edition, 1999 (additional sections on Sepsis Neonatorum, Congenital and Perinatal Infections including Varicella-Zoster Virus, Epstein-Barr Virus, Rubella, Toxoplasmosis); 4th Edition, 2005 (Cytomegalovirus, Herpes simplex virus, Neonatal Syphilis, Hepatitis viruses, Neisseria gonorrhoeae, Chlamydia trachomatis, Genital Mycoplasmas).

3. Sánchez PJ: Congenital Syphilis. In: Aronoff, SC (ed). Advances in Pediatric Infectious Diseases. Mosby-Year Book, Inc. 1992; Vol 7, 161-180.

56

4. Sánchez PJ: Syphilis. In: Burg FD, Ingelfinger JR, Wald ER (eds). Gellis and Kagan’s Current Pediatric Therapy. W.B. Saunders Company, 14th Edition, 1993, 590-592; 15th Edition, 1996, 622-624.

5. Ingall D, Sánchez PJ, Musher D: Syphilis. In: Remington JS, Klein JD (eds). Infectious Diseases of the Fetus and Newborn Infant, 4th Edition, 1995, 529-564; 5th Edition, Ingall D, and Sánchez PJ, 2000, 643-681.

6. Sánchez PJ: Miscellaneous Infections of Newborn (Chlamydia trachomatis) Infants, Genital Mycoplasma Infections, Candida Infections, Congenital Toxoplasmosis. In: Feigin RD and Cherry JD: Textbook of Pediatric Infectious Diseases, 4th ed., 1998, 926-940.

7. Sánchez PJ, Wendel GD: Syphilis in Pregnancy. In: Clinics in Perinatology: Infections in Pregnancy, 1998, 24:71-90.

8. Sánchez PJ: Laboratory tests for congenital syphilis. Concise Reviews of Pediatric Infectious Diseases, in Pediatr Infect Dis J 1998;17:70-71.

9. Sánchez PJ: 1998 Sexually Transmitted Diseases Treatment Guidelines, “Congenital Syphilis,” MMWR 1998;47:41-46.

10. Radolf JD, Sánchez PJ, Schulz KF, Murphy FK: Congenital Syphilis. In: Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, Wasserheit JN (eds). Sexually Transmitted Diseases, 3rd ed., 1999, 1165-1189.

11. Sánchez PJ: Syphilis and Pregnancy. In: Hitchcock PJ, MacKay HT, Wasserheit JN, Binder R (eds.). Sexually Transmitted Diseases and Adverse Outcomes of Pregnancy, 1999, 125-150 (Chapter 8), ASM press.

12. Sánchez PJ (moderator), Baker CJ, Kimberlin D: “Perinatal Infections”, in Pediatric UPDATE, American Academy of Pediatrics, April 2000, Volume 20.

13. Sánchez PJ: Immunoprophylaxis of Respiratory Syncytial Virus Disease. Pediatr Infect Dis J 2000;19:791-801.

14. Sánchez PJ: Immunoprophylaxis of Respiratory Syncytial Virus. Pediatr Infect Dis J 2002; 21:473-478.

15. Sánchez PJ: Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2002, “Congenital Syphilis,” in MMWR 2002; 51(No. RR-6):26-28.

16. Wendel GD, Jr., Sheffield JS, Hollier LM, Hill JB, Ramsey PS, Sánchez PJ: Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 2002;35 (Suppl 2):S200-9.

57 17. Sánchez, PJ: Perinatal infections and brain injury: current treatment options. Clin Perinatol 2002 Dec;29(4):799-826.

18. Sánchez PJ: “Viral and Miscellaneous Infections of the Fetus and Newborn: General Aspects of Viral Infections, Chlamydia trachomatis Infection, Mycoplasma and Ureaplasma Infections, Candida Infections, Congenital Toxoplasmosis”; “Syphilis.” In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL: Textbook of Pediatric Infectious Diseases, 5th ed., 2004, 866-929, 1724-1741.

19. Sánchez, PJ: Bacterial and fungal infections in the neonate: current diagnosis and therapy. In: Pollard AJ, McCracken GH, Jr., Finn A (eds.). Hot Topics in Infection and Immunity in Children, Advances in Experimental Medicine and Biology, Volume 2004;549:97-103.

20. Pablo J. Sánchez, Amina Ahmed. Toxoplasmosis, Malaria, and Tuberculosis. In: Taeusch HW, Ballard RA, Gleason CA: Avery’s Diseases of the Newborn, 8th ed., 2005, 530-550.

21. Mejías A, Chávez-Bueno S, Sánchez PJ. Respiratory Syncytial Virus Prophylaxis. NeoReviews,™ 2005;6:e26-e31.

22. Stehel EK, Sánchez PJ. Cytomegalovirus Infection in the Fetus and Neonate. NeoReviews,™ 2005;6:e38-e45.

23. Velaphi S, Sánchez PJ. Syphilis. In: Hutto C (ed.). Congenital and Perinatal Infections: A Concise Guide to Diagnosis. Humana Press, Totawa, NJ, 2005.

24. Kaufman D, Zanelli S, Sanchez PJ. Neonatal meningitis: Current Treatment Options. In Neurology: Neonatology Questions and Controversies. J. Perlman, editor., 2008; 2nd edition, 2012

25. Cantey JB, Sánchez PJ. Overview of Congenital Infections: The Prominence of Cytomegalovirus. Infect Disord Drug Targets. Robert Tolan, Jr., editor. 2011 Jun 30. [Epub ahead of print] PMID: 21827437

26. Cantey JB, Sánchez PJ. Neonatal herpes simplex virus infections: past progress and future challenges. Pediatr Infect Dis J. 2013;32(11):1205-7. PMID: 24141798

27. Dobson S, Sánchez PJ. Syphilis in Feigin RD, Cherry JD, Demmler GJ, Kaplan SL: Textbook of Pediatric Infectious Diseases, 6th ed., 2017

28. Lin Philana, Michaels M, Pablo J. Sánchez. Congenital Syphilis. In Teusch HW, Ballard RA, Gleason CA: Avery’s Diseases of the Newborn, 9th ed., 2017

ABSTRACTS

1. Sánchez PJ, Regan JA: Vertical transmission of Ureaplasma urealyticum. Pediatric Research, 1986 (Abstract 402A, poster presentation).

58

2. Sanocka U, Randel S, Sánchez PJ, Driscoll J, James LS: High incidence of late onset intracranial hemorrhage. Pediatric Research, 1986 (Abstract 467A, poster presentation).

3. Sánchez PJ, Regan JA: Ureaplasma urealyticum colonization and respiratory disease in preterm infants. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1986 (Abstract 281A, oral presentation).

4. Sánchez PJ, Regan JA: Vertical transmission of Ureaplasma urealyticum in preterm infants. Pediatric Research, 1987 (Abstract 420A, oral presentation).

5. Sánchez PJ, McCracken GH, Wendel GD, Norgard MV: Specificity of the fetal IgM response to Treponema pallidum antigens during congenital syphilis. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1987 (Abstract 190A, oral presentation).

6. Sánchez PJ, Cushion N, Threlkeld N, Dorne P, Siegel JD, McCracken GH: What is the significance of a positive urine group B streptococcal latex agglutination (LA) test in neonates? Pediatr Research, 1988 (Abstract 475A, poster presentation).

7. Sánchez PJ, Wendel G, Maberry M, McCracken GH, Norgard MV: Treponema pallidum infection of amniotic fluid and fetal outcome. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1988 (Abstract 239A, poster presentation).

8. Sánchez PJ, McCracken GH, Wendel G, Olsen KD, Threlkeld N, Norgard MV: IgM antibody to Treponema pallidum in CSF of infants with congenital syphilis. 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1988 (Abstract 239A, poster presentation).

9. Sánchez PJ, Wendel GD, McCracken GH, Norgard MV: Fetal IgM response to Treponema pallidum antigens in asymptomatic infants with suspected congenital syphilis. Pediatric Research, 1989 (Abstract 281A, poster presentation).

10. Sanocka U, Zauk A, Menken G, Apostolidou T, Sánchez P, Randel S, James LS: Does prenatal cocaine exposure increase the risk for brain lesions in low birth weight infants? Pediatric Research, 1989 (Abstract 230A, poster presentation).

11. Maberry M, Sánchez P, Ramin S, Davis L, Theriot S, Wendel G: Syphilis treatment failures in pregnancy. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1989 (Abstract 259A, poster presentation).

12. Sánchez PJ, Wendel GD, McCracken GH, Norgard MV: Congenital syphilis and HIV infection. Pediatric Research, 1990 (Abstract 276A, oral presentation).

59 13. Peters M, Harstad T, Sánchez P, Norgard M, Goldberg M, Wendel G: Prenatal diagnosis of congenital syphilis. Society of Perinatal Obstetricians, 1991 (Abstract, poster presentation).

14. Wendel G, Sánchez P, Farris R, Theriot S, Davis L: Treatment of syphilis in pregnancy. Society for Gynecologic Investigation, 1991 (Abstract, poster presentation).

15. Sánchez PJ, Wendel GD, Grimprel E, Goldberg MS, McCracken GH, Radolf JD, Norgard MV: Diagnosis of congenital neurosyphilis by the rabbit infectivity test and polymerase chain reaction. Pediatric Research, 1991 (Abstract 286A, poster presentation).

16. Sánchez PJ, Wendel GD, Hall M, Mayfield J, Eason M: Congenital Syphilis: the Dallas Experience. Pediatric Research, 1991 (Abstract 286A, oral presentation).

17. Mouzinho A, Rosenfeld CR, Sánchez PJ: Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatric Research, 1991 (Abstract 228A, poster presentation).

18. Sánchez PJ, Shelton S, Threlkeld N, Nelson JD: Comparison of broth-enhanced selective media to direct plating methods for detection of methicillin-resistant Staphylococcus aureus (MRSA). Abstracts of the 91st General Meeting of the American Society for Microbiology, No. C-231, p. 380 (Abstract, oral presentation).

19. Palmer AL, Sánchez PJ: Use of suprapubic bladder aspiration (SBA) for detection of group B streptococcal (GBS) antigen by latex agglutination (LA) in neonates. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, 1991 (Abstract 710A, oral presentation).

20. Sánchez PJ, Musher D: Congenital syphilis. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, 1991 (Abstract S-70B, invited lecture).

21. Nathan L, Twickler DM, Peters M, Sánchez PJ, Wendel GD: Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing. Society of Perinatal Obstetricians, Orlando, FL, 1992 (poster presentation).

22. Sánchez PJ, Wendel GD, Hall M, Diaz N, Norgard MV: What’s new in the diagnosis of congenital syphilis? Pediatric Research, 1992 (Abstract 710A, oral presentation).

23. Sánchez PJ, Hall M, Diaz N, Defazio P: Ureaplasma urealyticum (Uu) and chronic lung disease (CLD) in preterm infants. Pediatric Research, 1992 (Abstract #1669, poster presentation).

24. Perlman JM, Rollins N, Sánchez PJ: Late onset meningitis (LOM) in the sick very low birth weight (VLBW) infant. Pediatric Research, 1992 (Abstract #1664, poster presentation).

60 25. Chadwick EG, Millard DM, Rowley AH, Sánchez PJ: Congenital syphilis in HIV- infected and uninfected children in Chicago, 1989-1991. Pediatric Research, 1992 (Abstract #517, poster presentation).

26. Sánchez PJ, Shelton S, Threlkeld N, Fisher L, Sumner J, Grier CE: Randomized, double- blind, placebo-controlled evaluation of mupirocin ointment for eradication of methicillin- resistant Staphylococcus aureus (MRSA) in preterm infants. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1992 (Abstract, poster presentation).

27. Siegel JD, Cushion NB, Ross J, Sánchez PJ, Haley RW: Control of methicillin-resistant Staphylococcus aureus (MRSA) in a large special care nursery. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1992 (Abstract, oral presentation).

28. Scott L, Jackson G, Sánchez PJ, Castaneda Y, Hall M, Wendel G: Prevention of cesarean section for recurrent genital herpes simplex virus (HSV) using acyclovir suppressive therapy. Society for Gynecologic Investigation, 1993 (Abstract, oral presentation).

29. Anderson FJ, Barton JR, Sánchez PJ, Thorpe EM: Assessment of cerebrospinal fluid from pregnant patients with untreated syphilis: correlations with perinatal outcome. Society for Gynecologic Investigation, 1993 (Abstract, poster presentation).

30. Sánchez PJ, Palmer AL, Leos NK, Hall M: Urine collection for group B streptococcal latex agglutination testing in neonates: suprapubic bladder aspiration or bag specimen? Pediatric Research, 1993 (Abstract 295A, oral presentation).

31. Mouzinho A, Rosenfeld CR, Risser R, Sánchez PJ: Reference ranges for circulating neutrophils differ in very-low-birth-weight (VLBW, 1500gm) infants <60h of age. Pediatric Research, 1993 (Abstract 285A, poster presentation).

32. Sánchez PJ, Wendel GD, Leos NK, Hall M, Perlman JM, Evans D, Norgard MV: Determination of neonatal central nervous system invasion by Treponema pallidum by rabbit infectivity testing, polymerase chain reaction, and IgM immunoblotting: what constitutes neurosyphilis? 22nd National Meeting of the Child Neurology Society, 1993 (Abstract #123, oral presentation).

33. Sánchez PJ, Laptook A, Fisher L, Sumner J, Perlman J: Is apnea a hazard of immunization for preterm infants? 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1993 (Abstract #192, poster presentation).

34. Palmer A, Sánchez PJ, Cushion N, Siegel J: Neonatal group B streptococcal infection in a large county hospital: is it preventable? 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 1993 (Abstract #1399, poster presentation).

61 35. Nathan L, Bohman VR, Sánchez PJ, Leos NK, Wendel GD: In utero infection with Treponema pallidum in early pregnancy. Annual Meeting of the Society of Perinatal Obstetricians, 1994 (Abstract, oral presentation).

36. Sánchez PJ, Leos NK, Osorio MA, Zeray F, Wendel GD: Umbilical cord blood VDRL or RPR: what’s the difference? Pediatric Research, 1994 (Abstract #1803, poster presentation).

37. Osorio MA, Leos NK, Sánchez PJ: Prevalence of mycoplasmal meningitis in a neonatal intensive care unit (NICU). Pediatric Research, 1994 (Abstract #1794, poster presentation).

38. Sánchez PJ, Wendel GD, Zeray F, Leos NK, Mayfield J: Serologic follow-up in congenital syphilis: what’s the point? 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1994 (Abstract #L22, poster presentation).

39. Sanchez PJ, Osorio MA, Arevalo M, Leos NK, Zeray F, Risser R, Moya F: Colonization (Col) of the respiratory tract with ureaplasma urealyticum (Uu) following Exosurf (E) or Survanta (S) therapy and risk of chronic lung disease (CLD) in very-low-birth-weight (VLBW) infants (Inf). Pediatric Research, 1995 (Poster presentation).

40. Engle WD, Rosenfeld CR, Mouzinho A, Risser R, Zeray F, Sánchez PJ: Effect of sepsis on circulating neutrophils in low-birth weight (LBW) neonates 1500 grams. Pediatric Research, 1995 (Poster presentation).

41. Sánchez PJ, Wendel GD, Leos NK, Weigel LM, Zeray F, Radolf JD, Norgard MV: IgM immunoblotting utilizing recombinant 47- and 17-kDa antigens for diagnosis of congenital syphilis. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995 (Abstract #1173, poster presentation).

42. Wendel GD, Leveno K, Sánchez P, Jackson G, Cushion N, Siegel J: Prevention of neonatal group B streptococcal early onset sepsis by a combination of intrapartum ampicillin and neonatal penicillin. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996 (Abstract, poster presentation).

43. Sánchez PJ, Wendel GD, Radolf JD, Leos NK, Zeray F, Alsaadi R, Norgard MV: IgM immunoblotting, polymerase chain reaction (PCR), and rabbit infectivity testing (RIT) for congenital syphilis diagnosis: an update. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996 (Abstract, poster presentation).

44. Siva Subramanian KN, Weisman L, Rhodes T, Connor E, and the MEDI-493 Study Group: Randomized, double-blind, placebo-controlled, dose-escalation trial of a humanized respiratory syncytial virus (RSV) monoclonal antibody (MEDI-493) in high risk infants. The Society for Pediatric Research, 1997 (Abstract #768 130A, poster presentation).

62 45. Sánchez PJ, Zeray F, Priest C, Gard J, Leos NK, Alsaadi R, Hom RC: Pharmacokinetic analysis of clarithromycin in very-low-birth-weight infants colonized with Ureaplasma urealyticum. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997 (Abstract #A110, poster presentation).

46. Jafri H, Sheeran P, Saavedra J, Johnson C, Krisher K, Sánchez P, Ramilo O: Detection of IL-6, IL-8, IL-10, and RANTES in the nasopharyngeal (NP) and tracheal (TA) aspirates of children with respiratory syncytial virus (RSV) disease. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997 (Platform presentation #H-86).

47. Saez-Llorens X, Castaño E, Sánchez P, Ramilo O, Null E, Steichen J, Connor E, and the MEDI-493 Study Group: Phase I/II, Open-label, multi-dose escalation trial of a humanized respiratory syncytial virus (RSV) monoclonal antibody (MEDI-493) administered intramuscularly (IM) in high risk children. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28-October 1, 1997 (Poster presentation #H-89).

48. Sánchez PJ, Zeray F, Gard J, Leos NK, Alsaadi R, Hom RC: Pharmacokinetic analysis of clarithromycin in very-low-birth-weight infants colonized with Ureaplasma urealyticum. Fourth International Conference, January 21-23, 1998, (Poster Presentation #6.02).

49. Scott LL, Hollier LM, Baum A, Jackson G, Sánchez PJ, Wendel GD: Prevention of recurrent genital herpes at delivery using acyclovir suppression for herpes infection diagnosed prior to pregnancy – an interim analysis. Society of Perinatal Obstetricians, February 2-7, 1998.

50. Scott LL, Hollier LM, Jackson G, Sánchez PJ, Baum A, Wendel GD: Acyclovir suppression to prevent cesarean delivery after first episode genital herpes simplex infection. Society of Perinatal Obstetricians, February 2-7, 1998.

51. Sheffield JS, Alexander J, McIntire DD, Sánchez P, Wendel G: Serologic response after antepartum secondary syphilis treatment with one vs. two doses of benzathine penicillin G. Society of Perinatal Obstetricians, February 2-7, 1998 (Abstract #757).

52. Saez-Llorens X, Moreno MT, Ramilo O, Sánchez PJ, Conner EM, MI-CP009 Study Group: Phase I/II, double, blind, placebo-controlled, multi-dose escalation trial of a humanized respiratory syncytial virus (RSV) monoclonal antibody (MEDI-493) in children hospitalized with RSV. Society for Pediatric Research, New Orleans, LA, May 1-5, 1998 (Abstract #906, platform presentation).

53. De Vincenzo JP, Malley R, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, Sánchez PJ, Jafri H, Balsley J, Carlin D, Buckingham S, Vermacchio L, Ambrosino D: Viral concentration in upper and lower respiratory secretions from respiratory syncytial virus (RSV) infected children treated with RSV monoclonal antibody (MEDI-493). Society for Pediatric Research, New Orleans, LA, May 1-5, 1998 (Abstract #830, poster presentation).

63 54. Conner EM, Impact-RSV Study Group: Reduction of respiratory syncytial virus (RSV) hospitalization in children with prematurity or bronchopulmonary dysplasia (BPD) using intramuscular (IM) humanized monoclonal antibody to the RSV F-Protein (MEDI-493, Palivizumab; MI-CP018). Society for Pediatric Research, New Orleans, LA, May 1-5, 1998 (Abstract #824, platform presentation).

55. Phillips DY, Moody B, Luby J, Boney L, Sánchez PJ: Influenza A among infants and staff in a neonatal intensive care unit: double jeopardy. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998 (Abstract K-48, poster presentation).

56. Sánchez PJ, Gard JW, Dao R, Leos NK, Perlman J: Impact of a protocol for reduction of vancomycin use in a neonatal intensive care unit. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998 (Abstract #K-23, poster presentation).

57. Sheffield JS, Wendel GD, Zeray F, Leos NK, Alsaadi R, Sánchez PJ: Congenital syphilis: the influence of maternal stage of syphilis on vertical transmission. Society for Maternal- Fetal Medicine, San Francisco, CA, February 1999 (Abstract, poster presentation).

58. Sheffield JS, Morris G, Holler L, Zeray F, Sánchez PJ, Wendel GD: Syphilis treatment failures in pregnancy. Society for Maternal-Fetal Medicine, San Francisco, CA, February 1999 (Abstract, poster presentation).

59. Mohamed WA, Cushion N, Siegel JD, Gaffney D, Byrd L, Leos NK, Sánchez PJ: Discontinuation of antibiotics in neonates: when does the blood culture become positive? Southern Society for Pediatric Research, Oral presentation, New Orleans February 18-20, 1999; Poster presentation (Abstract #793), Pediatric Academic Societies Meeting, San Francisco, CA, May 1999.

60. Jafri HS, Carubelli CM, Sheeran P, Saavedra J, Sánchez PJ, Ramilo O: Systemic IL-6, IL- 8, and RANTES response in children with respiratory syncytial virus disease. Pediatric Academic Societies Meeting, San Francisco, CA, May 1999 (Poster presentation).

61. Carubelli CM, Jafri HS, Sánchez PJ, Ramilo O: Ribavirin suppresses pro-inflammatory cytokines production in pulmonary epithelial cells infected with respiratory syncytial virus. Pediatric Academic Societies Meeting, San Francisco, CA, May 1999 (Poster presentation).

62. Null DM, Connor EM, and the Palivizumab Study Group: Evaluation of immunogenicity and safety in children receiving Palivizumab for a second RSV season. Pediatric Academic Societies Meeting, San Francisco, CA, May 1999 (Poster presentation).

63. Sánchez PJ, Mohamed WA, Gard JW, Gaffney D, Byrd L, Zeray F, Leos NK: Use of a vancomycin-reduction protocol in a neonatal intensive care unit: what’s the outcome? 37th

64 Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, November 1999 (Poster presentation).

64. Wendel GD, McIntire DD, Sánchez PJ, Jackson GL, Leveno KJ: Impact of a combined intrapartum and neonatal group B streptococcus prevention program: an eleven-year experience in 157,120 live births. Society for Maternal-Fetal Medicine, Miami Beach, FL, January 31-February 5, 2000.

65. Rogers B, Sheffield J, Margraf L, Fong D, McIntire D, Zeray F, Sánchez PJ, Wendel G: Placental villous enlargement correlates with poor pregnancy outcome in congenital syphilis. Society for Pediatric Pathology, New Orleans, March 2000 (Poster presentation).

66. Teran S, Walsh C, Finelli L, Chesson H, Irwin KL, Wendel G, Sánchez P: Cost- effectiveness analysis of presumptive treatment regimens for neonates congenitally exposed to syphilis. CDC EIS Meeting, April 1999 (Poster presentation).

67. Michelow IC, Wendel GD, Zeray F, Leos NK, Norgard MV, Sánchez PJ: Clinical and laboratory markers of central nervous system invasion by Treponema pallidum in congenital syphilis. Pediatric Academic Societies Meeting, Boston, MA, May 12-16, 2000 (Abstract 344A, #2030).

68. Sumner J, Fisher L, Sánchez PJ: Immunization status of siblings of very-low-birth-weight infants in the neonatal intensive care unit: another missed opportunity? Pediatric Academic Societies Meeting, Boston, MA, May 12-16, 2000 (Abstract 347A, #2049).

69. Velaphi SC, Siegel JD, Wendel GD, Eid W, Sheffield J, Sánchez PJ: Early-onset group B streptococcal (GBS) disease following institution of a GBS preventive strategy: why the continued occurrence? 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, September 7-10, 2000, (Abstract #25, p. 44, Oral presentation). 70. Kimberlin DW, Lin C-Y, Sánchez PJ, Demmler G, Dankner W, Shelton M, Edwards K, Jacobs RF, Robinson J, Wright J, Lakeman FD, Kiell JM, Soong S-J, Whitley RJ, and the NIAID Collaborative Antiviral Study Group (CASG): Ganciclovir treatment of symptomatic congenital cytomegalovirus (CMV) infections: results of a phase III randomized trial. Oral presentation, 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, Canada, September 17-20, 2000 (ICAAC Program Committee Award recipient in the area of Therapy of Microbial Diseases).

71. Velaphi SC, Gard JW, Barton PJ, Jackson GL, Stehel EK, Owen KE, Shalak LF, Martin KA, Shoup AG, Sánchez PJ: Development of a nomogram for once-daily dosing of gentamicin in term and near-term newborns. Pediatric Academic Societies Meeting, Baltimore, MD, April 28-May 1, 2001 (Poster presentation)

72. Goodman B, Sumner J, Zeray F, Sánchez PJ: Apnea after immunization of very-low- birth-weight infants: a second look after use of the acellular pertussis vaccine. Pediatric Academic Societies Meeting, Baltimore, MD, April 28-May 1, 2001 (Poster presentation)

65

73. Sánchez PJ, Rubin LG, Siegel JD, Levine GL, Jarvis WR, and the Pediatric Prevention Network: Late-onset sepsis: a survey of neonatal intensive care unit practices. Pediatric Academic Societies Meeting, Baltimore, MD, April 28-May 1, 2001 (Poster presentation).

74. Velaphi SC, Cushion NB, Ihionkhan CE, Sánchez PJ, Siegel JD: Early-onset sepsis and penicillin-resistant pathogens during group B streptococcal chemoprophylaxis: is there a relationship? Pediatric Academic Societies Meeting, Baltimore, MD, April 28-May 1, 2001 (Poster presentation).

75. Velaphi SC, Siegel JD, Cushion NB, Sánchez PJ: Early-onset sepsis in very-low-birth- weight infants during group B streptococcal chemoprophylaxis: Here come the Gram- negatives? 39th Annual Meeting of the Infectious Diseases Society of America (IDSA), San Francisco, CA, October 25-28, 2001 (Abstract #10, oral presentation).

76. Bradford RD, Kimberlin DW, Lakeman FD, Cloud G, Boppana SB, Britt WJ, Sánchez P, Demmler G, Dankner W, Shelton M, Jacobs RF, Whitley RJ, and the NIAID Collaborative Antiviral Study Group (CASG): Baseline viremia in congenital cytomegalovirus (CMV) infection correlates with clinical outcome. 39th Annual Meeting of the Infectious Diseases Society of America (IDSA), San Francisco, CA, October 25-28, 2001 (Abstract #37).

77. Velaphi SC, Gard JW, Jackson GL, Stehel EK, Frawley WH, Shalak LF, Martin KA, Sánchez PJ: Development and validation of a nomogram for once-daily dosing of Gentamicin in term and near-term newborns. Pediatric Academic Societies’ Meeting, Baltimore, MD, May 4-7, 2002, (Abstract 1765, poster presentation).

78. Sumner JL, Goodman B, Bush MA, Badhwar P, Sánchez PJ: Immunization of very-low- birth-weight infants in the neonatal intensive care unit (NICU) with Prevnar: is it OK? Pediatric Academic Societies Meeting, Seattle, WA, May 2-6, 2003 (Abstract 1774, poster presentation).

79. Stehel EK, Shoup AG, Owen KE, Jackson GL, Boney LF, Sánchez PJ. Universal Newborn Hearing Screening for Detection of Congenital Cytomegalovirus Infection: How Good Is It? Pediatric Academic Societies Meeting, San Francisco, CA, May 1-4, 2004 (poster symposium).

80. Heyne NG, Gonzalez JR, Sheffield JS, Laibl V, Wendel GW, Trevino S, Sendelbach DM, Jackson GL, Sánchez PJ. Maternal Influenza at Delivery: Risky Business for the Infant? Pediatric Academic Societies Meeting, Washington DC, May, 2005 (poster presentation).

81. Restrepo AV, Chung WM, Rodriguez-Cerrato V, Jafri HS, Booth T, Carroll T, Ahmad N, Cavuoti D, Sánchez PJ. Use of Polymerase Chain Reaction and Cerebral Magnetic Resonance Imaging for Diagnosis of Herpes Simplex Virus Encephalitis in Early Infancy:

66 Friends or Foes? Pediatric Academic Societies Meeting, Washington DC, May, 2005 (poster presentation).

82. Losonsky G, Fernandez P, Abarca K, Jung E, Gerdes J, Hultquist M, Connor E, and for the Numax Study Group. Phase 1/2 Trial in High Risk Infants of MEDI-524 (Numax), an Enhanced Potency Respiratory Syncytial Virus (RSV) Specific Monoclonal Antibody. Pediatric Academic Societies Meeting, Washington DC, May, 2005 (poster presentation).

83. Santos R, Sánchez PJ, Mejias A, Benjamin DK, Walsh TJ, Jafri HS. Pharmacokinetic Evaluation of Voriconazole and Micafungin for Cutaneous Aspergillosis in a Preterm Infant. St. Jude/PIDS Pediatric Microbial research Conference, Memphis, TN, 2/24- 25/2006 (poster presentation).

84. Sánchez PJ, Cotton CM and NICHD Neonatal Research Network (NRN). Antimicrobial Therapy for Necrotizing Enterocolitis: Practice Variations and Clinical Outcome. Pediatric Academic Societies’ Meeting, San Francisco, CA, April/May, 2006 (poster presentation).

85. Oliver S, Cloud G, Sánchez P, Demmler G, Dankner W, Shelton M, Jacobs R, Vaudry W, Pass R, Soong S, Whitley R, Kimberlin D. Effect of Ganciclovir Therapy on Neurodevelopmental Outcomes in Symptomatic Congenital Cytomegalovirus Infections Involving the Central Nervous System: A Randomized, Controlled Study. Pediatric Academic Societies’ Meeting, San Francisco, CA, April/May, 2006 (poster presentation).

86. Clipp K, Trevino S, Ahmad N, Benfatti L, Chiles E, Graffeo A, Kuehn S, Moore E, Nathan S, Pittman C, Reed H, Yarborough L, Anderson J, Sánchez PJ. Interventions to Reduce Percutaneously Inserted Central Venous Catheter (PICC)-Associated Bloodstream Infections (BSI): What Works? Pediatric Academic Societies’ Meeting, San Francisco, CA, April/May, 2006 (poster presentation).

87. Smith JR, Messina A, Ewing P, Siegel JD, Brock EE, Sánchez PJ. Hepatic Dysfunction during Acute Influenza Infection in Children: How Common is it? 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), October 12-15, 2006, Toronto, Canada (poster presentation).

88. Ardura M, Mejias A, McCracken, Jr. GH, Sánchez PJ. Daptomycin Therapy for Multi- drug Resistant (MDR) Gram-Positive Bacterial Infections in Children. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), October 12-15, 2006, Toronto, Canada (poster presentation). 89. Santos RP, Sánchez PJ, Salvatore CM, Prestidge CB, Brown ME, Urbanczk B, McCracken GH, Jafri HS, Siegel JD. The Use of Linezolid in Pulmonary Exacerbation Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) among Children with Cystic Fibrosis. St. Jude/PIDS Pediatric Microbial research Conference, Memphis, TN, 2/2007 (poster presentation).

67 90. Fonseca-Aten M, Green M, Michaels M, Charsha-May D, Friedman B, Seikaly M, Sánchez P. Respiratory Syncytial Virus (RSV) Prophylaxis Among Solid Organ Transplant (SOT) Programs.4th Congress of the International Pediatric Transplant Association, Cancun, Mexico, March 17-21, 2007 (oral presentation).

91. Duryea E, Sánchez PJ, Sheffield J, Jackson G, Wendel G. McElwee B, Boney L, Engle W, Stehel E. Maternal Human Immunodeficiency Virus (HIV) Infection and Vertical Transmission of Cytomegalovirus (CMV). 45th Medical Student Research Forum, UT Southwestern Medical Center, Dallas, TX, January 16, 2007 (poster presentation).

92. Duryea E, Sanchez PJ, Sheffield J, Jackson G, Wendel G, McElwee B, Boney L, Mallory M, Engle W, Stehel E. Maternal Human Immunodeficiency Virus (HIV) Infection and Vertical Transmission of Cytomegalovirus (CMV). Pediatric Academic Societies’ Meeting, May 4-8, 2007, Toronto, Canada (poster presentation).

93. Carbonell X, Losonsky G, Hultquist M, Connor E, the Motavizumab Study Group. Phase 3 Trial of Motavizumab (MEDI-524), an Enhanced Potency Respiratory Syncytial Virus (RSV) Specific Monoclonal Antibody (Mab) for the Prevention of Serious RSV Disease in High Risk Infants. Pediatric Academic Societies’ Meeting, May 4-8, 2007, Toronto, Canada (poster presentation).

94. Mejias A, Bustos R, Ramirez C, Ardura MI, Sánchez PJ, Persistence of Herpes Simplex Virus (HSV) DNA by Polymerase Chain Reaction (PCR) in Cerebrospinal Fluid (CSF) of Neonates (NEO) with HSV Encephalitis. Pediatric Academic Societies’ Meeting, May 4- 8, 2007, Toronto, Canada (poster presentation).

95. Santos RP, Gard J, Adams-Huet B, Ruparel J, Leff R, Bush M, Martin K, Tharayl S, Olesen B, Vedro D, Binson J, Stehel E, Sánchez PJ. Validation of a Random Concentration-Time Curve (GENT Curve) for Once-Daily Dosing of Gentamicin (GENT) among Infants  35 Weeks Gestation. Pediatric Academic Societies’ Meeting, May 4-8, 2007, Toronto, Canada (poster presentation).

96. Santos RP, Prestidge CB, Brown ME, Urbanczyk B, Murphy DK, Sánchez PJ, Salvatore CM, McCracken GH, Jafri HS, Siegel JD. Linezolid (LZD) Use in Children with Cystic Fibrosis (CF): Potential Role of CF Transmemberane Regulator (CFTR) Gene Mutations on Drug Clearance? 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17-20, 2007, Chicago, Illinois (poster presentation).

97. D’Angio CT, Sanchez PJ, Heyne R, Schnable KC, Hall CB. Influenza Vaccine Immunogenicity in Extremely Premature Infants. Pediatric Academic Societies’ Meeting, May 2-6, 2008, Honolulu, Hawaii (poster presentation).

98. Sanchez PJ, Murphey D, Hauger S, Brown O, Gaglani M, Leach C, Siegel J, Pennfield S and TX Pediatric Society Committee of Infectious Disease & Immunizations. Sentinel Site Surveillance of Respiratory Virus (RSV) Infections in Texas (TX): Implications for

68 Prophylaxis. Pediatric Academic Societies’ Meeting, May 2-6, 2008, Honolulu, Hawaii. (poster presentation).

99. Santos RP, Chang Y, de Oliveira C, Adams-Huet B, Gard J, Sanchez PJ. Dosing Regimen of Gentamicin (GENT) and Effect of Antenatal Steroids on Clearance (CL) in Preterm Infants. Pediatric Academic Societies’ Meeting, May 2-6, 2008, Honolulu, Hawaii. (poster presentation).

100. Brasel LE, Sanchez PJ. Use of the MedVac Immobilizer for Magnetic Resonance Imaging (MRI) Among Infants in the Neonatal Intensive Care Unit (NICU) and Newborn Nursery (NBN): Does It Reduce the Need for Sedation? Pediatric Academic Societies’ Meeting, May 2-6, 2008, Honolulu, Hawaii. (poster presentation).

101. Brion LP, Wyckoff MH, Jaleel MA, Sanchez PJ, Burchfield J, Christie L. Delivery Room Practice Change Following the Initiation of the NICHD Support Trial. Pediatric Academic Societies’ Meeting, May 2-6, 2008, Honolulu, Hawaii. (poster presentation).

102. Benjamin Jr DK, Smith PB, Arrieta A, Castro L, Sanchez P, Kaufman D, Arnold L, Kovanda L, Sawamoto T, Buell DN, Hope WW, Walsh TJ. (PPRU) Safety and Pharmacokinetics (PK) of Repeat-Dose Micafungin (MICA) in Neonates. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Washington, DC, October 25-28, 2008 (poster presentation).

103. Chung WM, Gonzales M, Sheffield J, Wendel GD, Mayfield J, Carlo J, Sanchez PJ. Recent trends in reported Infectious Syphilis in Women and Infants in Dallas County. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Washington, DC, October 25-28, 2008 (poster presentation).

104. Evans A, Mejias A, Cooper T, Gomez A, Sanchez PJ. Acyclovir-Induced Nephrotoxicity: A Case Report St. Jude/PIDS Pediatric Microbial Research Conference, Memphis, TN, 2/2009 (poster presentation).

105. Thompson TD, Goodman B, Sumner J, Patredis G, Heyne RJ, Sanchez PJ. Rotavirus Vaccination of Very-Low-Birth-Weight (VLBW) Infants at Nursery Discharge: Is Another Strategy Needed? Pediatric Academic Societies’ Meeting, May 2-5, 2009, Baltimore, MD (poster presentation).

106. Wharton M, Talley D, Gard J, Chang Y, Jaiswal A, Sanchez PJ, and NICU Infection Control Committee. Influenza Immunization of Infant Contacts in the Neonatal Intensive Care Unit (NICU): It Can Be Done! Pediatric Academic Societies’ Meeting, May 2-5, 2009, Baltimore, MD (poster presentation).

107. Benjamin Jr DK, Smith PB, Arrieta A, Castro L, Sanchez PJ, Kaufman D, Arnold L, Kovanda L, Sawamoto T, Buell DN, Hope WW, Walsh TJ. Safety and Pharmacokinetics

69 of Repeat-Dose Micafungin in Neonates and Young Infants. Pediatric Academic Societies’ Meeting, May 2-5, 2009, Baltimore, MD (poster presentation).

108. Boppana S, Ross S, Novak Z, Shimura M, Britt W, Tolan R, Palmer A, Ahmed A, Michaels M, Sanchez P, Bernstein D, Fowler K. Utility of dried blood spot PCR to screen newborns for congenital CMV infection. Pediatric Academic Societies’ Meeting, May 2- 5, 2009, Baltimore, MD (platform presentation).

109. DuPont TL, Chalak LF, Morriss M, Heyne R, Wyckoff M, Wang JZ, Burchfield J, Miller N, Morgan J, Boatman C, Salhab WA, Sanchez PJ. Implementation of Systemic Hypothermia for Hypoxic-Ischemic Encephalopathy (HIE): What s the Outcome? Pediatric Academic Societies’ Meeting, May 2-5, 2009, Baltimore, MD (poster presentation).

110. Boppana SB, Ross SA, Novak Z, Chowdhury N, Palmer A, Ahmed A, Michaels M, Sanchez P, Bernstein D, Tolan R, Fowler KB. Saliva PCR for Newborn Screening. 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, October 29-November 1, 2009 (platform presentation).

111. Ross S, Fowler K, Novak Z, Chowdhury N, Ahmed A, Michaels M, Sanchez P, Bernstein D, Tolan R, Palmer A, Boppana S. Utility of Direct Real-Time PCR on Newborn Urine to Detect and Quantify Cytomegalovirus. 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, October 29-November 1, 2009 (poster presentation).

112. Evans AS, Mejias A, Cooper T, Sanchez PJ. Acyclovir-Associated Renal Dysfunction on Children. 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, October 29-November 1, 2009 (poster presentation).

113. Kimberlin D, Acosta E, Sanchez P, Ampofo K, Vanchiere J, Englund J, Sood S, Lang D, Caserta M, Abzug M, Abughali N, Michaels M, Spigarelli M, Wan W, Jester P, Griffin J, Whitley R, for NIAID Collaborative Antiviral Study Group (CASG). Oseltamivir pharmacokinetics (PK) in infants: Interim results from multicenter trial. 47th Annual Meeting of The Infectious Diseases Society of America (IDSA), Philadelphia, PA, October 29-November 1, 2009 (platform presentation).

114. Andi L. Shane, Pablo J. Sánchez, Nellie I. Hansen, Barbara J. Stoll, GDB Subcommittee for NICHD Neonatal Research Network. Epidemiology of Methicillin Resistant (MRSA) and Sensitive (MSSA) Staphylococcus aureus (MRSA) Infections among Very Low Birth Weight (VLBW) Neonates in the NICHD Neonatal Research Network (NRN). Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (oral presentation).

115. Eduardo Lopez-Medina, Monica I. Ardura, Evangeline Brock, Jane D. Siegel, Pablo J. Sánchez. 2009 H1N1 Influenza in Hospitalized Infants < 6 Months of Age. Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (oral presentation).

70 116. Suresh Boppana, Shannon Ross, Nazma Chowdhury, Zdenek Novak, Marian Michaels, Pablo Sánchez, et al. Dried Saliva PCR for Screening Newborns for Congenital CMV Infection. Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (oral presentation).

117. Ross S, Fowler K, Novak Z, Chowdhury N, Michaels M, Sánchez P, Bernstein D, Tolan R, Palmer A, Ahmed A, Boppana S. Relationship between Dried Blood Spot Positivity and Viral Load in the Urine and Saliva of Infants with Congenital Cytomegalovirus Infection. Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (oral presentation).

118. Garcia C, Tucker C, Leff R, Sánchez PJ, Ardura MI. Pharmacokinetics (PK) of Peramivir in a Child during Extracorporeal Membrane Oxygenation (ECMO) and Continuous Venous-Venous Hemofiltration (CVVHD). Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (poster presentation).

119. Ira Adams-Chapman, Carla M. Bann, Ron Goldberg, Danny Benjamin, Barbara J. Stoll, Michelle Walsh, Pablo Sanchez, Rose Higgins, Seetha Shankaran, Kristi Watterburg, Abhik Das, for the NICHD Neonatal Research Network. Neurodevelopmental Outcome of ELBW Infants with Candida Infection. Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (poster presentation).

120. Tara L. DuPont, Lina F. Chalak, Roy Heyne, Michael C. Morriss, Pablo J. Sanchez. Evaluation of Infants for Hypothermia Therapy: How Good Is the Neurological Examination for Detection of Hypoxic-Ischemic Encephalopathy (HIE)? Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (poster presentation).

121. Lina F. Chalak, Luc P. Brion, Michael C. Morris, Jeannette Burchfield, Lucy Christie, Pablo J. Sanchez. Biochemical Screening Criteria for Assessment of Hypoxic-Ischemic Encephalopathy (HIE): How Do They Apply to the Late Preterm Infant? Pediatric Academic Societies’ Meeting, May 1-4, 2010, Vancouver, Canada (poster presentation).

122. DW Kimberlin, RJ Whitley, W Wan, DA Powell, G Storch, A Ahmed, A Palmer, PJ Sánchez, et al, for the NIAID Collaborative Antiviral Study Group: Impact of oral acyclovir suppression on neurodevelopmental outcomes and skin recurrences following neonatal herpes simplex virus disease. 48th Annual Meeting of The Infectious Diseases Society of America, Vancouver, British Columbia, October 21-24, 2010; Abstract #2977.

123. Carlos R. Oliveira, Alicia Guzman, Diana Vasil, Nancy Miller, Pablo J. Sánchez. Race and Ethnicity of Mothers with Spanish Surnames. Pediatric Academic Societies Meeting, Denver, CO, April 30-May 3, 2011; Abstract #1450.551 (poster presentation).

124. Natasha W. Hanners, Sylvia Trevino, Pranavi Sreeramoju, Jane D. Siegel, Mambarath A. Jaleel, Pablo J. Sánchez. Eradication of Vancomycin-Resistant Enterococcus faecium (VRE) from a Neonatal Intensive Care Unit (NICU): It Can Be Done! Pediatric Academic

71 Societies Meeting, Denver, CO, April 30-May 3, 2011; Abstract #3818.159 (poster presentation).

125. Joseph B. Cantey, Asuncion Mejias, Christopher Doern, Evangeline Brock, Rebecca Wallihan, Douglas Salamon, Mario Marcon, Pablo J. Sánchez. Use of Blood Polymerase Chain Reaction (PCR) for Diagnosis of Herpes Simplex Virus (HSV) Infection. Pediatric Academic Societies Meeting, Denver, CO, April 30-May 3, 2011; Abstract #3820.171 (poster presentation).

126. Tara L. DuPont, Lina F. Chalak, Nancy Rollins, Michael C. Morriss, Roy Heyne, Pablo J. Sánchez, MD. Neurodevelopmental Outcomes and Brain MRI Findings in Infants Treated with Systemic Hypothermia for Hypoxic-Ischemic Encephalopathy (HIE). AAP, Boston, MA, 10/14/2011 (poster).

127. Shannon Ross, Sunil Pati, Nitin Arora, Karen Fowler, Zdenek Novak, Amina Ahmed, April Palmer, Marian Michaels, Pablo J. Sánchez, Robert W. Tolan Jr, David I. Bernstein, Suresh Boppana. Cytomegalovirus Strain Diversity in Newborns with Congenital Infection. 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2011 (poster).

128. Shannon Ross, Nitin Arora, Zdenek Novak, Pablo J. Sanchez, Robert W. Tolan Jr., David Bernstein, Amina Ahmed, April Palmer, Marian Michaels, Masako Shimamura, Karen Fowler, Suresh Boppana. Salivary shedding of cytomegalovirus in children with congenital infection. 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2011 (poster).

129. Joseph Cantey, Susan Bacsik, Greg Jackson, Jeanne Sheffield, Sylvia Trevino, Pablo J. Sanchez. Mother-to-Infant Transmission of 2009 H1N1 Influenza in the Postpartum Period: How Best to Prevent It? 49th Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2011 (poster).

130. Cantey JB, Lopez-Medina E, Sánchez PJ, et al. Serious Bacterial Infection (SBI) in Early Infancy: Are We Over-Treating? Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/1/2012 (poster).

131. Lopez-Medina E, Cantey JB, Ardura MO, et al. Mortality in Neonatal Herpes Virus (HSV) Infection: Frustration Persists! Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/1/2012 (poster).

132. Cantey JB, Sánchez PJ. Antiquity to Ubiquity: The History of Neonatal Herpes Simplex Virus (HSV) Infection. Pediatric Academic Society Annual Meeting, Boston, MA, 4/28- 5/1/2012 (poster).

133. Dulaurier ME, Cantey JB, Dietrich A, Mihalov L, Sanchez PJ, Ramilo O, Mejias A. Empiric Versus Targeted Acyclovir (ACV) for Neonatal Herpes Simplex Virus (HSV) Infection. Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/1/2012 (platform).

72

134. Cantey JB, Treviño S, Siegel JD, et al. A Fatal Outbreak of Extended-Spectrum Beta Lactamase Producing Klebsiella pneumoniae (ESBL-Kp) in a Neonatal Intensive Care Unit (NICU). Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/1/2012 (poster).

135. Stumpf KA, Burchfield JP, Sánchez PJ. The Conundrum of Urinary Tract Infections among Preterm Infants in the Neonatal Intensive Care Unit. Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/1/2012 (poster).

136. Wiltrakis SM, Cloud GA, Whitley RJ, Sánchez PJ, et al. Predictors of Influenza Disease Severity and Resolution in Infants: Results of a National Collaborative Trial. Pediatric Academic Society Annual Meeting, Boston, MA, 4/28-5/2/2012 (poster).

137. Ronchi A, Sheffield JS, Wendel GD, Ansari Q, Barton T, Mallory M, Sánchez PJ. Impact of New Texas State Law of Maternal Screening for Human Immunodeficiency Virus (HIV) Infection: How Are We Doing? Pediatric Academic Societies’ Annual Meeting, Boston, MA, April 28-May 1, 2012 (poster).

138. Ronchi A, Torres L, Boatman C, Zeray F, Owen KE, Shoup AG, Varghese S, Sánchez PJ. Developmental Outcomes of Children with Congenital Cytomegalovirus (CMV) Infection. IDWeek, San Diego, October 17 – 21, 2012 (poster).

139. Cantey, JB, Chung W, Siegel JD, et al. Infant Pertussis: Where are the Holes in Our Cocoon? IDWeek, San Diego, CA. 2012 (poster).

140. Cantey JB, Wallihan R, Mejias A, et al. Persistent Herpes Simplex Virus (HSV) DNAemia in Neonatal HSV Infection: What’s the Outcome? IDWeek, San Diego, CA, 2012 (poster).

141. Joyner S, Ripp Z, Vidal E, Cantey JB, et al. Perinatal Hepatitis B Virus Infection in Dallas County: Why its Continued Occurrence? IDWeek, San Diego, CA, 2012 (poster).

142. Olivera C, Morriss MC, Mistrot J, Cantey JB, et al. Magnetic Resonance Imaging (MRI) of the Brain of Infants with Bacterial Meningitis. IDWeek, San Diego, CA, 2012 (poster).

143. Ronchi A, Torres L, Boatman C, Zeray F, Owen KE, Shoup AG, Cantey JB, Varghese S, Sánchez. Evaluating the “Asymptomatic” Infant with Congenital Cytomegalovirus (CMV) Infection: How Useful is It? 4th Congenital Cytomegalovirus Conference, 10/29-31/12 (oral and poster presentation).

144. Ronchi A, Sánchez PJ. Neonatal Adenovirus Infection: A 16 Year Review! Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

145. Ronchi A, Michelow IC, Chapin KC, Fasihuddin F, Mannino C, Moses J, Ma Shum J,

73 Sanchez PJ. Viral Respiratory Infections (VRI) in the Neonatal Intensive Care Unit (NICU): The VIRIoN-I Study. Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

146. Lal CV, Cantey JB, Varghese S, Trevino S, Scheid L, Jaleel M, Sanchez PJ. Obtaining Blood Cultures (BC) in the Neonatal Intensive Care Unit (NICU): Central, Peripheral or Both? Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

147. Stumpf KA, Sanchez PJ. Urinary Tract Infection (UTI) in Preterm Infants: A Prospective Cohort Study. Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

148. Chalak LF, Zhang R, Sanchez P, Laptook A. Cerebrovascular Dysfunction in Newborns with Hypoxic Ischemic Encephalopathy (HIE): Can Non-Responders Be Identified during Therapeutic Hypothermia (TH)? Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

149. Truog W, Nelin L, Das A, Kendrick D, Higgins R, Stoll B, Walsh M, Bell E, Carlo W, Laptook A, Sanchez P, Shankaran S, Van Meurs K, NICHD Neonatal Research Network. Inhaled Nitric Oxide Usage in the NICHD Neonatal Research Network: Inter-Site Variability and Propensity Evaluation. Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (poster).

150. Cantey JB, Wozniak P, Sanchez PJ. Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU): Improvement Needed! Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (oral; PIDS Blue Ribbon).

151. Boppana SB, Ross S, Sanchez P, Bernstein D, Michaels MG, Tolan, Jr. R, Ahmed A, Pamer AL, Fowler KB. Evaluation of Dried Blood Spot PCR To Detect Infants with Symptomatic Congenital Cytomegalovirus Infection and Hearing Loss. Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (oral).

152. Ross SA, Shimamura M, Palmer A, Ahmed A, Michaels M, Sanchez P, Bernstein D, Tolan R, Novak Z, Chowdhury N, Britt W, Fowler K, Boppana S. Detection of Congenital Cytomegalovirus Infection Using Real-Time Polymerase Chain Reaction or Culture of Saliva or Urine: Which Is Better? Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (oral).

153. Chalak LF, Sanchez PJ, Heyne RJ, Torres L, Morriss MC, Rollins NK. Brain Magneti Resonance Imaging (MRI) and Bayley Scales of Infant Development (BSID) III Following Systemic Hypothermia: A Five Year Prospective Cohort Study. Pediatric Academic Societies’ Annual Meeting, Washington, DC. May 4-7, 2013 (oral).

154. Nguyen S, Nickerson D, Ronchi A, Doern CD, Heyne RJ, Siegel JD, Sánchez, PJ. Improving the Timing of Palivizumab Immunoprophylaxis: Can Use of Local Respiratory

74 Syncytial Virus (RSV) Prevalence Help Define the Season? IDWeek, 10/2-6/13, San Francisco, CA (poster).

155. Pinninti S, et al. Longitudinal salivary CMV shedding in a cohort of infants with congenital CMV. IDWeek 10/2-6/2013, San Francisco, CA (oral presentation)

156. Kimberlin DW, Jester PM, Sanchez PJ, Ahmed A, Arav-Boger R, Sood SK, Woods C, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, Tolan RW, DeBiasi RL, Han J-Y, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths P, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Aban I, Acosta EP, Whitley RJ, for the NIAID Collaborative Antiviral Study Group (CASG). Six months versus six weeks of oral valganciclovir for infants with symptomatic congenital cytomegalovirus (CMV) disease with and without central nervous system (CNS) involvement: Results of a Phase III, randomized, double-blind, placebo-controlled, multinational study. IDWeek 2013 (annual meeting of the Pediatric Infectious Diseases Society, the Infectious Diseases Society of America, the HIV Medical Association, and the Society for Healthcare Epidemiology of America), San Francisco, CA, October 2-6, 2013 (Oral – late breaker presentation).

157. Hanners NW, Sreeramoju P, Treviño S, Siegel JD, Jaleel MA, Ronchi A, Mistrot J, Len J, Sánchez PJ. Investigating an Outbreak of Vancomycin-Resistant Enterococcus faecium (VRE) in a Neonatal Intensive Care Unit (NICU): What Were the Risk Factors for Infant Colonization? St. Jude/PIDS Pediatric Infectious Diseases Research Conference February 24-25, 2014, Memphis, TN (poster).

158. Cantey JB, Stagno SB, Sanchez PJ. Protozoa, Parotids, and Progress: the Convoluted History of Congenital Cytomegalovirus (cCMV) Infection, Pediatric Academic Societies’ Annual Meeting, Vancouver, BC, May 3-6, 2014 (poster).

159. Pinninti S, Ross S, Rodgers M, Shimamura M, Palmer A, Ahmed A, Sanchez P, Michaels M, Bernstein D, Feja K, Stewart A, Fowler K, Boppana S. Characteristics of Symptomatic Congenital CMV Infection: Findings from the NIDCD CHIMES Study Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster)

160. Karen B. Fowler, Shannon A. Ross, Masako Shimamura, Amina Ahmed, April L. Palmer, Marian G. Michaels, David I. Bernstein, Pablo J. Sanchez, Kristina Feja, Audra Stewart. Racial Disparities and the Prevalence of Congenital Cytomegalovirus (CMV) Infection: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

161. Pyle AK, Cantey JB, Brown LS, Heyne RJ, Heyne E, Atok A, Brammer E, Lair C, Sanchez PJ. Antibiotic Exposure in Very-Low-Birth-Weight (VLBW) Infants in the NICU: Another Marker for Obesity? Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

75 162. Cantey JB, Wozniak PS, Sanchez PJ. The Conundrum of Pneumonia Treatment in the NICU: Can Variation Inform Antibiotic Stewardship? Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

163. Wozniak PS, Cantey JB, Zeray F, Leos NK, Sheffield J, Wendel GD, Sanchez PJ. Nineteen Years of Congenital Syphilis (CS) in Dallas: Progress and Persistence! Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (platform).

164. White NO, Cantey JB, Dulaurier M, Mejias A, Sanchez PJ. Management of Newborns Delivered To Women With Active Genital Herpes Simplex Virus (HSV) Lesions: Is Current Guidance Optimal? Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (platform).

165. Boppana S, Ross S, Pinninti S, Palmer A, Ahmed A, Sanchez P, Michaels M, Bernstein D, Pati S, Feja K, Stewart A, Fowler K. Association Between Blood Viral Load and Symptomatic Congenital CMV Infection and Hearing Loss at Birth: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (platform).

166. Oliver SE, Pinninti SG, Pati SK, Palmer AL, Ahmed A, Feja K, Bernstein DI, Michaels MG, Sanchez PJ, Stewart A, Fowler KB, Boppana SB, Ross SA. Saliva Viral Load in Symptomatic Congenital CMV Infection and CMV-Associated Hearing Loss at Birth: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (platform).

167. Ronchi A, Torres L, Zeray F, Boatman C, Owen KE, Shoup AG, Cantey JB, Varghese S, Cheetham S, Ahmed A, Michaels M, Pugni L, Mosca F, Sanchez PJ. How Asymptomatic Is the “Asymptomatic” Neonate With Congenital Cytomegalovirus (cCMV) Infection? Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (platform)

168. Chalak LF, Lucke A, Nelson D, McIntire D, Sanchez P, Leveno KJ. Obstetric Antecedents for Neonatal Encephalopathy (NE) and Systemic Hypothermia Therapy (SHT). Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

169. Watson J, Spencer J, Cohen D, Sanchez P, Hains D. Outpatient Management of Presumed Urinary Tract Infection (UTI) in the Emergency Department (ED) – Another Challenge in Antimicrobial Stewardship. Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

170. Fowler KB, Ross SA, Shimamura M, Ahmed A, Palmer AL, Michaels MG, Bernstein DI, Sanchez PJ, Feja K, Stewart A. Adolescent Pregnancies and the Risk of Congenital Cytomegalovirus (CMV) Infection: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies’ Annual Meeting Vancouver, BC, May 3-6, 2014 (poster).

171. Cantey JB, Wozniak PS, Sánchez PJ. Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU): Metrics Matter! IDWeek, 10/8-12/14, Philadelphia, PA (poster).

76

172. Abzug MJ, MD, Michaels M, Wald E, Jacobs R, Romero J, Sanchez P, Wilson G, Krogstad P, Storch G, Lawrence R, Shelton M, Palmer A, Robinson J, Dennehy P, Sood S, Cloud G, Jester P, Acosta EP, Whitley R, Kimberlin D, and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis. IDWeek, 10/8-12/14, Philadelphia, PA (platform).

173. Cooper JM, Porter MC, Bazan JA, Sanchez PJ. Re-Emergence of Congenital Syphilis in Ohio. Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (platform).

174. Pyle AK, Cantey JB, Wozniak PS, Hynan LS, Sanchez PJ. Antibiotic Exposure and Adverse Outcomes in Preterm, Very-Low-Birth-Weight (VLBW) Infants: Each Day Matters! Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

175. Cantey JB, Wozniak PS, Sanchez PJ. Surveillance and Correction of Unnecessary Antibiotic Therapy (SCOUT) in the Neonatal Intensive Care Unit (NICU): It Can Be Done! Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (platform).

176. Cantey JB, Langer JC, Stoll BJ, Sánchez PJ, and NICHD Neonatal Research Network (NRN). Duration of Antimicrobial Therapy for Bloodstream Infections (BSI) in Very- Low-Birth-Weight (VLBW) Infants: Implications for Antibiotic Stewardship Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

177. Cooper JM, Porter MC, Bazan JA, Sanchez PJ. Re-Emergence of Congenital Syphilis in Ohio. Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (platform).

178. Cantey JB, Wozniak PS, Sanchez PJ. Surveillance and Correction of Unnecessary Antibiotic Therapy (SCOUT) in the Neonatal Intensive Care Unit (NICU): It Can Be Done! Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (platform).

179. Cantey JB, Langer JC, Stoll BJ, Sánchez PJ, and NICHD Neonatal Research Network (NRN). Duration of Antimicrobial Therapy for Bloodstream Infections (BSI) in Very- Low-Birth-Weight (VLBW) Infants: Implications for Antibiotic Stewardship Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

180. Moyer K, Salamon D, Leber A, Simsic J, Ramilo O, Sanchez PJ, Mejias A. Impact of Preoperative Respiratory Viral Screening in Children Undergoing Cardiac Surgery. Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

77 181. Yossef Salameh L, Sanchez P, Reagan P, Slaughter L, SlaughterJ. Anticonvulsant Treatment of Neonatal Seizures: Changing Use Demands More Evidence! Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

182. White NO, Cantey JB, Mejias A, Sanchez PJ. Screening for Neonatal Herpes Simplex Virus (HSV) Infection with Serum Alanine Aminotransferase (ALT): How Good Is It? Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 30-30- May May (poster).

183. Wozniak PS, Cantey JB, Zeray F, Leos NK, Sheffield JS, Wendel GD, Sanchez PJ. Neonates with Normal Physical Examination and Nonreactive Nontreponemal Test Results: What's the Risk for Congenital Syphilis? Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (poster).

184. Moallem M, Talavera M, Cantey JB, Shane AL, Nelin L, Stoll BJ, Sánchez PJ. Twelve Years of Bloodstream Infections (BSI) and Meningitis in Preterm Infants with Necrotizing Enterocolitis (NEC): The BSI-NEC Study. Pediatric Academic Societies’ Annual Meeting, San Diego, CA. April 25-28, 2015 (platform).

185. Ouellette C, Sanchez PJ, Smith B, Zeray F, Torres L, Ronchi A, Cantey JB, Ramilo O, Mejias A. Blood Whole Genome Expression Profiles in Congenital Cytomegalovirus Infection (cCMVi): Is the Asymptomatic Infant Truly Asymptomatic? IDWeek, San Diego, CA. 10/7-11/15

186. Moyer K, Wang H, Salamon D, Haines J, Sanchez PJ, Ardura MI, Mejias A, Leber A. Impact of Enterovirus D68 in Children with Asthma and Other Complex Medical Conditions. IDWeek, San Diego, CA. 10/7-11/15

187. Firestine AM, Ulloa J, Shepherd EG, Sanchez PJ. Therapeutic Hypothermia within Six Hours for Neonatal Encephalopathy: Is It Always Possible? Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

188. Rajah B, Garcia-Maurino C, Gruber P, Sanchez PJ, Ramilo O, Mejias A. Impact of the Revised Guidelines for Respiratory Syncytial Virus (RSV) Prophylaxis: A Single Center Experience. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (platform)

189. McDonald B, Foor N, Nelin L, Sánchez PJ. Type of Milk Feeding at Discharge from the Neonatal Intensive Care Unit and Neurodevelopmental Outcomes: Breast Continues to be Best! Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

190. Ouellette CP, Ronchi A, Mejías A, Salamon D, Leber A, Pugni L, Sánchez PJ. Detection of Cytomegalovirus (CMV) from Saliva in Infants Undergoing Sepsis Evaluation in the Neonatal Intensive Care Unit. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

78

191. Vicetti-Miguel CP, Garcia Moreno J, Mejias A, Leber A, Sanchez PJ. A Decade of Antimicrobial Resistance in Staphylococcus aureus (SA) and Associated Outcomes in Pediatric Patients: An Emerging Problem? Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (platform)

192. Yossef-Salameh L, Sanchez PJ, Reagan PB, Slaughter L, Firestine A, Slaughter J. Anticonvulsant Therapy and Hypoxic-Ischemic Encephalopathy (HIE) in the Hypothermia Era. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

193. Cooper JM, Porter M, Bazan JA, Staat MA, Sanchez PJ. Understanding the Epidemic of Congenital Syphilis in Ohio: Lessons Learned. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

194. Cantey JB, Wozniak PS, Sánchez PJ. Antifungal Use and Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU): Two Birds with One Stone. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

195. Wozniak PS, Moallem M, Mejías A, Durrani-Kolarik S, Sánchez PJ. Detection of Respiratory Viruses in the Neonatal Intensive Care Unit (NICU): It’s Important! Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

196. Ramser M, Shimamura M, Mejias A, Salamon D, Leber A, Sanchez PJ. The Conundrum of Postnatal Detection of Cytomegalovirus (CMV) Among Infants in the Neonatal Intensive Care Unit (NICU): A Call for Universal CMV Screening! Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

197. White NO, Cantey JB, Mejias A, Zeray F, Morriss MC, Sánchez PJ. Brain Magnetic Resonance Imaging (MRI) in Neonatal Herpes Simplex Virus (HSV) Infection: Impact on Disease Classification and Treatment. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

198. Ross S, Sanchez P, Bernstein D, Michaels M, Ahmed A, Palmer A, Feja K, Stewart A, Fowler K, Boppana S. Dried Blood Spot PCR as a Marker for Hearing Loss in Congenital Cytomegalovirus Infection. Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (platform)

199. Garfinkle J, Prempunpong C, Chalak L, Rollins N, Thayyil S, Sanchez P, Pappas A, Nguyen KA, Shah B, Kalra V, Mir I, Boyle R, Shankaran S, Laptook A, Sant'Anna G. Prospective Research in Infants with Mild Encephalopathy – the PRIME study Pediatric Academic Societies Annual Meeting, Baltimore, MD, April – May 3, 2016 (poster)

200. Vicetti Miguel C, Mejias A, Leber A, Sanchez PJ. A Decade of Antimicrobial Resistance of Staphylococcus aureus (SA) in Cystic Fibrosis (CF): A Widespread Problem! IDWeek 2016, New Orleans, LA 10/27-30/2016 (poster)

79 201. Wozniak PS, Rajah B, Sanchez PJ, Gruber P, Magers J, Ramilo O, Mejias A. Impact of the Revised Guidelines for Respiratory Syncytial Virus (RSV) Prophylaxis: Morbidity Persists After Two Seasons! IDWeek 2016, New Orleans, LA 10/27-30/2016 (oral presentation)

202. Morvarid Elahi M, Sumner J, Gard J, Fisher L, Sánchez PJ. Randomized, Placebo- Controlled Trial of DTwP Vaccine in Preterm, Very-Low-Birth-Weight (VLBW) Infants in the Neonatal Intensive Care Unit (NICU): Was Apnea a Problem? IDWeek 2016, New Orleans, LA 10/27-30/2016 (oral presentation)

203. Ramser M, Shimamura M, Mejias A, Salamon D, Leber A, Sanchez PJ. Postnatal Cytomegalovirus (CMV) Testing in the Neonatal Intensive Care Unit (NICU): Why? IDWeek 2016, New Orleans, LA 10/27-30/2016 (poster presentation)

80